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ABSTRACT 
This study investigates the rise of the Attention-Deficit/Hyperactivity Disorder diagnosis. 
It approaches the topic from a medicalization perspective and frames it under the 
therapeutic state as proposed by Nicholas Kittrie in 1971. It asks three questions: how 
has society, and particularly, the medical community changed to allow the 
medicalization of hyperactivity and social control of active children? How has the 
continuing diagnosis of hyperactivity in children expanded to include attention deficit 
hyperactivity disorder in both children and adults? And what forces are behind the 
continuously inclusive diagnosis and why? In an attempt to answer these questions the 
history of the diagnosis is followed from its inception through the present. Special 
attention is paid to studies of causality, stimulant medication, evolving diagnostic 
criteria, and research that place the topic within a social framework. Sources include 
reputable experts in the field, respected journalists, and organizational data, including 
the United States Government. Major theorists consulted include Nicholas A. Kittrie, 
Peter Conrad, and Max Weber. It concludes that the psychiatric community, drug 
companies and individuals are responsible for the disorder’s medicalization. Further, 
research into ADHD has not yielded results consistent or significant enough to justify a 
sick label. 
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 1 
Introduction 
 
ADHD is “the most commonly diagnosed behavioral condition in children” (Reiff & 
Tippins, 2004, Introduction). The average informed American is most likely familiar with 
the term. Since its popularization, the diagnosis has permeated American culture, and 
has, in some ways, become fashionable (Jergen, 2004). Some may not know ADHD 
stands for Attention Deficit Hyperactivity Disorder but because it is a cultural 
phenomenon, people are often familiar with the acronym and who it represents. 
YouTube, the popular streaming video website, is plastered with videos of children and 
adults who reportedly have ADHD. With the recent play written by former Sex and the 
City actress Cynthia Nixon, Distracted, there is little doubt that ADHD has permeated 
our culture (Cox, 2008). Caricaturized versions of hyperactive children are ubiquitous. 
Mike Myers’ Saturday Night Live character Phillip was a hyperactive boy fitted with a 
safety helmet and harnessed to playground equipment (NBC). Phillip provides an 
excellent example of the power a label can have. The skit shows that ADHD has 
become a significant part of our culture. Television programs respond to viewer ratings; 
if there were not enough people interested in the topic of a skit, it would not be aired. 
The dispute over ADHD - its treatment, causes, and even existence - has 
continued for decades. In fact, this was a debate within the medical and psychological 
communities for much of the 20th century and is now continuing into the 21st century 
(Fourier, 2009). The National Institute of Mental Health (2008) claims that ADHD is “one 
of the most common mental disorders in children and adolescents” (p. 17). In fact, a 
2007 report claimed ten percent of children in Tennessee are diagnosed with the 
disorder (Pinto, 2007). 
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Among the general public, ADHD is now synonymous with hyperactivity and 
inattention, much like Kleenex and Xerox are synonymous with tissues and making 
copies respectively. It is not uncommon to hear people say things in conversation like “I 
think I have ADHD” or “sometimes I get ADHD.” This kind of language is, no doubt, 
indebted to the expansion of the diagnosis to include not only children, but adults as 
well. What was once a childhood disorder for most of the 20th Century has inflated to the 
point where it could currently affect any person in the population. This expansion has 
opened the door to profiteers reaping enormous benefits from the continuation of the 
diagnosis. While lay people and professionals alike are still debating the existence of 
the disorder, one thing is certain; before the 20th century hyperactivity was rarely 
mentioned but by the end of the first decade of the 21st Century, millions of people are 
being diagnosed and treated with psychotropic, mind altering drugs.  
The popularity of the ADHD diagnosis is not an isolated incident; it coincided with 
the rise of the therapeutic state in the early 1970s. The medical and psychiatric 
communities dramatically increased their influence on western culture during this period 
(Kittrie, 1977). The term “medicalization” was coined to explain how the medical 
community has increasingly taken control of deviant behaviors (i.e., alcoholism, 
depression, drug addiction) and made them part of their domain (Conrad, 1992; Szasz, 
2007). Medicine in the United States has now become big business, at times advertising 
directly to the public and bypassing the physician altogether. Everyday occurrences 
such as sadness, activity, and pregnancy are linked to medical interventions such as 
anti-depressants, stimulants, and unnecessary Cesarean sections.  
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Those who embrace medicalization theory are apt to point out that this takeover 
is a form of social control (Conrad, 1992; Szasz, 2007). In the psychiatric world, many of 
the diagnoses are based not on biological evidence, but behavioral evidence that 
stresses the presence of social disruption. Treatment is often prescribed to reduce or 
minimize social disruption on the basis of observation and surveys. Consequently many 
social delinquents and deviants, rather than being diverted to the criminal justice 
system, are being controlled by the psychiatric system (Kittrie, 1977). Treatment is often 
used in lieu of incarceration. No longer confined to criminal deviants or social misfits, 
medication is now often given to children to treat socially deviant “symptoms” such as 
talking in class and not sitting still in a wooden chair for hours on end. 
ADHD is the most commonly treated socially disruptive childhood disorder. 
Prescribing drugs to children diagnosed with ADHD in order to induce them to sit still at 
school is a form of social control because it literally controls their social behavior. In less 
than a century, the medical community created a new diagnosis for deviant behavioral 
patterns and now treats these patterns with psychotropic drugs known to produce a 
myriad of serious side effects. Furthermore, the evidence to support the claim that 
ADHD is a disorder is unproven (Baughman & Hovey, 2006). Even one of ADHD’s 
staunchest supporters admits that the behaviors could simply be a natural phenomenon 
(Barkley, 2000). This hyperactive and inattentive behavior was almost entirely ignored 
by the medical community prior to the 20th century. It was subsequently labeled deviant 
by a medical community that showed passive interest in the disorder by mid-century, 
and finally labeled a sickness that required a treatment intervention by a large segment 
of the medical and psychological communities towards the end of the 20th Century. 
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Discussion over ADHD has changed little; the same debate that started in the 
1930s continues. The questions must be raised; how has society, and particularly, the 
medical community changed to allow the medicalization of hyperactivity and social 
control of active children? How has the continuing diagnosis of hyperactivity in children 
expanded to include attention deficit hyperactivity disorder in both children and adults?  
And finally, what forces are behind the continuously inclusive diagnosis and why? 
Chapter 1 contains a theoretical overview.  It lays the foundation for considering 
the rise of ADHD popularity within the medicalization framework. This portion contains 
theoretical ideas from Peter Conrad, Nicholas Kittrie, Max Weber, and Erving Goffman. 
Chapter 2 discusses specific points of ADHD including a description of the diagnosis, its 
prevalence, and the cultural impact on America. Chapter 3 discusses the treatment 
options available for the disorder. Chapters 4 through 8 contain a chronological social 
history of the diagnosis. Finally, Chapter 9 provides theoretical discussion of the 
significance of western culture on the development of the disorder. 
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Chapter 1 
Review of Social Theories on Medicalization 
 
In his 1971 work, The Right to be Different: Deviance and Enforced Therapy, 
Nicholas Kittrie discussed the rise of what he called the therapeutic state. Kittrie made 
insightful predictions of the future of criminality and the social control of deviance. He 
contended that the social control of deviance would increasingly be undertaken by the 
medical community. He described psychiatry as an enforcer of society’s behavioral 
norms. Kittrie’s theories were criminological and his focus was on the civil rights of the 
mentally ill subjected to forced institutionalization. His reflections, however, can be 
extended to include the medication of western culture since his manuscript was written. 
With every diagnosis and treatment prescribed to modify an individual’s behavior, the 
psychiatric community controls behaviors considered socially disruptive. When active 
and assertive children are routinely prescribed a drug similar to cocaine (National 
Institutes of Health, 2009), Kittrie’s concerns about the therapeutic state become more 
prophetic. 
The therapeutic state has two unique characteristics. The first of these is a shift 
from a religious explanation of criminal and deviant behaviors to a more secular one 
that “speaks not in terms of moral judgment…but in concepts reputed to be descriptive 
and scientific” (Kittrie, 1977, p. 39). This has accompanied a general change from the 
sacred to the secular in the United States. Previously unexplained phenomena that 
were once attributed to angels, demons, and God are now often explained by science. 
Therefore, we no longer say that social deviants are possessed by demons but rather 
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that they are sick and need treatment. This observation does not favor demonic 
possession as an explanation; it simply states that the change has occurred. 
Another characteristic of the therapeutic state is the extension of an English 
governing ideal known as parens patrae. Parens patrae gave the state the right and 
responsibility to become a parental figure for those deemed unfit to care for themselves. 
It gave the English monarchs certain control over the affairs of children and the mentally 
ill during the Middle Ages (Kittrie, 1977). It was primarily a law created to protect 
property but the idea of government as a benevolent parent has been incorporated into 
United States legislation. The government has enacted legislation regarding the rights, 
treatment, incarceration, and protection of juveniles and the mentally ill. Some of these 
laws enable the medical and psychiatric communities to act for the benefit of the 
mentally ill, often against their will. While this can be a positive addition to society, it also 
opens the door for maltreatment and exploitation of those who deviate from the norms 
and institutions of society. The spirit of parens patrae can clearly be seen in the actions 
of the psychological community. 
The therapeutic state is a logical extension of what Weber (1946) described as 
an increased rationalization of society. The mechanization of society demands 
streamlined efficiency. “Precision, speed, ambiguity, knowledge of files, continuity, 
discretion, unity, strict subordination, reduction of friction, and of material and personal 
costs” are “raised to the optimum point” in a bureaucracy (p. 214). A rationalized society 
is a highly structured and ordered world where standing in line, bureaucratic red tape, 
and filling out the right forms are necessities. People know their place in the social 
structure, they are aware of and obey their superiors, and they exist as one of many. 
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Heretofore the justice and the economic systems have been charged with enforcing this 
kind of order. Because the bureaucracy strives for increased efficiency in human 
interaction, social deviants are seen as counter productive. When traditional social 
institutions were unable to socially control law abiding, yet deviant, citizens the 
bureaucracy created an institution that could. It is a social enforcement tool born of 
medical science and humanity’s tireless efforts to conform. When enforcing norms on 
“sick” individuals, pills are the preferred choice because they are quick, easy, and 
efficient. The therapeutic state, however, cannot wantonly medicate anyone; it must 
bring behaviors under its domain by the process of medicalization. 
Medicalization, which literally means “to make medical” (Conrad, 1992, p. 210), 
happens when an everyday occurrence is defined in medical terms, uses medical 
language to describe it, and places its conceptualization in a medical framework 
(Conrad, 1992). Conrad & Schneider (1992) picked up where Kittrie left off saying, 
“Some say that rehabilitation has replaced punishment, but in many cases medical 
treatments have become the new form of punishment and social control” (p. 1). Since its 
conception, the term has generally taken on a negative connotation. It is often used in 
social critique; some go so far as to call psychiatric medicalization slavery (Szasz, 
2007). Others claim that medicalization itself is not inherently negative (Conrad, 2007).  
The prevailing view is that medicalization is primarily negative by expression or 
implication. Often the psychiatric community bears the brunt of negative accusations. 
Szasz asserted that, “although medicalization encompasses more than psychiatry, we 
must be clear about one thing: Psychiatry is medicalization, through and through” 
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(Szasz, 2007, p. xx). However, psychologists and psychiatrists take the view they are 
helping the social deviant. Goffman (1967) claimed:  
Persons who come to the attention of a psychiatrist typically come to the 
attention of their lay associates first. What psychiatrists see as mental illness, the 
lay public usually first sees as offensive behavior – behavior worthy of scorn, 
hostility and other negative social sanctions. The objective of psychiatry all along 
has been to interpose a technical perspective: understanding and treatment is to 
replace retribution; and a concern for the interests of the offender is to replace a 
concern for the social circle he has offended. I refrain from enlarging here on how 
unfortunate it has been for many offenders to have been granted this medical 
good fortune. (p. 137) 
Goffman painted a picture of the psychiatric community as an agent of misguided 
social control. A clear illustration of the subjective and political nature of the process of 
medicalization is that homosexuality was transformed from sinful to a medical condition 
when medical science conceptualized it as such. It became a “nondisease when the 
homosexual lobby became powerful and troublesome enough to force psychiatrists to 
abolish the diagnosis” (Szasz, 2007, p. xviii). This view holds the psychiatric community 
as enforcers of society’s norms. If true, psychiatrists as a group can sometimes be the 
proverbial wolf in sheep’s clothing. 
There are three factors that underlie medicalization. The first of these is the 
“power and authority of the medical profession, whether in terms of professional 
dominance, physician entrepreneurs, or, its extremes, medical colonization” (Conrad, 
2005, p. 4).  The expansion of the medical field was a prime mover for medicalization. 
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The medical community has most certainly extended its power; this was inevitable as 
technology expanded. At one point doctors were regarded as little more than butchers 
and now society highly respects them. This has only happened only within the last 
century. The medical community has assimilated mental health and troublesome 
behavior in children within its sphere of influence, thereby expanding the treatment of 
childhood disorders. 
Secondly, medicalization can emerge as a consequence of special interest 
groups and social movements; “In these cases, organized efforts [are] made to 
champion a medical definition of a problem or to promote the veracity of a medical 
diagnosis” (Conrad, 2007, p. 9). Grassroots movements can also be effective catalysts 
for social change (Conrad, 2007). Children and Adults with Attention Deficit Disorder 
(CHADD) was formed by parents of ADHD children who were concerned with gathering 
reliable information on the disorder. It has been a very active lobbying group that has 
dedicated substantial time and energy to promoting the idea that ADHD is a real 
disorder. It has even lobbied the government on occasion for certain special 
compensations. Various forms of the disorder were recognized before CHADD’s 
founding; however, ADHD still did not gain popular favor until the late 1980s and 1990s 
(Armstrong, 1997). This was the time period when CHADD became very active in the 
establishment of the diagnosis (DeGrandpre, 1999).  
Thirdly, medicalization happens due to “directed organizational or inter- or 
intraprofessional activities” (Conrad, 2007, p. 9). Conrad (2007) explains that 
“professions competed for authority in defining and treating problems” (p. 9). In a 
profession where one distinguishes oneself by discovery, these individuals may see 
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disorders and diseases where none exist. Some entrepreneurs are under-stimulated 
doctors establishing themselves in a cut throat field (Conrad, 1992). This could be done 
innocently; years of training and working in the medical or psychiatric fields will define 
how one conceives social reality. Dismissing any devious plot against the diagnosed, 
doctors actually believe that some social deviancy is a sickness. Goffman describes the 
behavior of putting sick labels on unpopular behaviors and beliefs. He asserted: 
Although it is easy enough to call psychotic behavior social deviancy, it is even 
easier to see that there are many types of social deviancy that are not instances 
of psychotic behavior—even though brave psychiatrists and psychologists have 
tried to get at the sick roots of everything from crime to political disloyalty. 
(Goffman, 1967, p. 140) 
It is under these conditions that medicalization takes place. Medicalization is a means to 
which the therapeutic state brings deviant behaviors under its control and the 
therapeutic state is an enforcement institution in the bureaucracy.   
To fully understand the medicalization of the disorder, a basic understanding of 
the history of the ADHD diagnosis and where it currently stands is needed. There are 
two basic views of ADHD; one view classifies it as a mental disorder and one view holds 
it to be a natural state of humanity. Those who believe it is natural are often at odds with 
the psychiatric treatment; in fact, the treatment with medication is an important factor of 
any discussion of the disorder. Many have weighed in on this discussion both in 
academia and popular culture. Chapter 2 discusses these issues as well as the cultural 
impact the disorder has had on American society, showing the importance of the study 
of ADHD from a sociological framework.  
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Chapter 2 
An Overview of the ADHD Diagnosis and its Cultural Impact 
 
Minimal Brain Damage, Hyperkinesis, Hyperactive Child Syndrome, Hyperactive 
Reaction of Childhood, Attention Deficit Disorder, and Adult ADD are all terms used to 
describe what is now Attention-Deficit/Hyperactivity Disorder. Those who are diagnosed 
with ADHD are active and inattentive children and adults. These are the ones who 
cannot sit still; the ones who go at life full throttle and neglect to pay attention in class or 
at work or sometimes when spoken to. ADHD is a multifaceted disorder that has come 
to represent much beyond its original hyperactive definition. It is wrong to say ADHD 
children and adults are simply hyperactive and impulsive.  
A plethora of private and public organizations offer expert information on ADHD. 
Also, individual doctors have become experts on the subject, having served years in the 
field. Many of these individuals have written medical and theoretical books on the 
disorder, some having become classic ADHD literature. The debates on the disorder 
are often a key point in many of these manuscripts. The opinions of these professionals 
may differ, but many are well respected in their field. Some are strong advocates of the 
disorder and its treatment with stimulants; others are strong critics. This suggests that 
while ADHD is a cultural phenomenon, it is still hotly debated. There are many 
documents that have become classics in the field; however, the Diagnostic and 
Statistical Manual of Mental Disorders has become the go-to document for diagnosis. 
During the first half of the 20th century, there was no standard, no official guide 
to diagnosing mental disorders; as a consequence, several terms were used for the 
same behaviors. In an attempt to standardize the identification of mental illness, the 
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American Psychiatric Association published the first edition of the Diagnostic and 
Statistical Manual of Mental Disorders in 1952. Although the first edition was a limited 
publication, it soon became widely accepted as the key diagnostic manual in treating 
mental disorders (Connor, 1999). The DSM is a growing document. Since its initial 
publication, it has been revised several times. It was not until the second edition that the 
DSM (1968) recognized hyperactivity in children as a disorder. Today the DSM has 
such widespread acceptance that one would be hard pressed to find a mental health 
facility that does not use one. This is, in part, because it is easier to avoid insurance 
lawsuits if diagnosing based on the manual (Gavirina, 2001). Since its original 
publication, it has become the proverbial bible of mental disorders (Connor, 1999).  
The most recent edition of the Diagnostic and Statistical Manual of Mental 
Disorders, the DSM-IV-TR (2000), recognizes not only ADHD, but also four unique 
subtypes. To accomplish this, the DSM breaks the criteria into two categories, 
hyperactive and inattentive, each with a set of qualifications. If seven of these 
qualifications are met in either category, a diagnosis is given. Those meeting the criteria 
under the hyperactive category are diagnosed Attention Deficit/Hyperactivity Disorder, 
Predominantly Hyperactive Type. Those meeting the criteria under the inattentive 
category are diagnosed Attention Deficit/Hyperactivity Disorder, Predominantly 
Inattentive Type. Individuals who meet an appropriate number of qualifications to be 
diagnosed with both are categorized as Attention Deficit/Hyperactivity Disorder, 
Combined Type. The label Attention Deficit/Hyperactivity Disorder, Not Otherwise 
Specified is reserved for those who do not meet the criteria for the other three types but 
the diagnostician feels they warrant an ADHD diagnosis nonetheless. This is to serve as 
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a catch-all for those who do not fit the criteria for the other categories. Brief mention is 
given to the possibility of Attention Deficit/Hyperactivity Disorder in remission. This is 
reserved for those who once qualified for an ADHD diagnosis but no longer do. It is 
often attributed to aging out. 
According to the current DSM, 3-7% of school aged children suffer from ADHD. 
This is a higher percentage than previous editions. The DSM-IV-TR (2000) admits that: 
Prevalence of Attention-Deficit/Hyperactivity Disorder as defined in the DSM-IV 
may be somewhat greater than the prevalence of the disorder based on the 
DSM-III-R criteria because of the inclusion of the Predominantly Hyperactive-
Impulsive and Predominantly Inattentive Types. (p. 90) 
This shows that the eligibility criteria are expanding. The age of onset, according to the 
DSM, should be measured at 7 years and it cautions against labeling and treating 
children under 4 or 5 because developmental issues are likely to skew any 
interpretation of ADHD symptoms. The DSM (2000) admits “there are no laboratory 
tests, neurological assessments, or attentional assessments that have been established 
as a diagnostic in the clinical assessment of Attention-Deficit/Hyperactivity Disorder” (p. 
88-89) Also, “there are no specific physical features associated with Attention-
Deficit/Hyperactivity Disorder” (p. 89) This firmly establishes ADHD as a behavioral 
disorder with no undisputable biological evidence. 
The most recent version of the manual includes other statistics and points of 
interest about ADHD. According to the DSM (2000): 
On average, individuals with Attention-Deficit/Hyperactivity Disorder obtain less 
schooling than their peers and have poorer vocational achievement. Also, on 
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average, intellectual level, as assessed by individual IQ tests, is several points 
lower in children with this disorder than compared with peers. (p. 88) 
 The DSM also claims that about half of the clinic-referred children with ADHD have 
Oppositional Defiant Disorder or Conduct Disorder as well. These disorders are 
characterized by behavior that is hostile, aggressive, and anti-social. The rate of co-
occurrence with other disorders is very high. Other associated disorders include; 
Disruptive Behavior Disorders, Mood Disorders, Anxiety Disorders, Learning Disorders, 
and Communication Disorders. A high incidence of ADHD occurs among children with 
Tourette’s Disorder ; and there “may be a history of child abuse or neglect, multiple 
foster placements, neurotoxin exposure…, infections…, drug exposure in utero, or 
Mental Retardation” (p. 88).  
The DSM has been met with controversy on many occasions. Much of this has to 
do with reliability and validity of interpretations. Psychologist Michael G. Conner (1999) 
described one of these criticisms: 
The DSM does have merit. When correctly used, the DSM is very highly reliable. 
But this just means that a group of professionals using the DSM will often reach a 
similar diagnosis. The concerns expressed by scientists and practitioners are that 
the conclusions, although reliable, are often wrong and may do more harm than 
good. (p. 3) 
There are even more insidious accusations that illustrate general flaws in the mental 
health system. Some have pointed out the political nature of the document, saying 
certain mental illnesses are voted into existence when it fits the trends of society to do 
so, and conversely voted out of existence when those trends change. Homosexuality is 
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one of the most cited examples of this practice (Szasz, 2007). While homosexuality was 
once viewed as a mental disorder, to call it that now would be politically incorrect. 
Conversely, to not recognize ADHD as a mental disorder is politically incorrect because 
those who champion it are cohesive enough to constitute a political power. This 
exemplifies the subjectivity of psychiatric labeling. 
Another concern about the validity of the DSM has to do with funding. In a PBS 
Frontline interview, Dr. Merrill Goozner, the director of the Integrity in Science Project at 
the Center for Science in Public Interest, offered examples of the DSM’s bias: 
If you looked at, for instance, the obsessive compulsive disorder latest guidelines 
[in the DSM-IV, the Diagnostic and Statistical Manual of Mental Disorders] for 
how to treat this, it was something like 10 out of 11 physicians on the panel had 
conflicts of interest in that they had taken money from antidepressant 
manufacturers or from drug manufacturers who had made antidepressants that 
had indications for treating obsessive compulsive disorder. (Gaviria, 2008) 
This is an assertion echoed about the mental health field as a whole. Psychiatrists and 
doctors accepting money from drug manufacturers has long been a sticking point for 
critics. 
While some are in disagreement, this has not impeded the advance of the 
diagnosis. The popularity of mental disorders, and particularly ADHD, is growing. The 
annual rate of increase for the ADHD diagnosis in the United States was an average of 
3% between 1997 and 2006 (U.S. Dept of Health and Human Services, 2008). As of 
2006, 4.5 million children in the United States ages 5-17 have been diagnosed with the 
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disorder (U.S. Dept of Health and Human Services, 2007) and as of 2003, 2.5 million 
children 4-17 years old were receiving medical treatment for the disorder.  
This growing diagnosis, which has recently been expanded to include adults, was 
first thought to be only a childhood disorder. Though the sick label is a modern 
convention, the behavioral patterns have been around much longer, and are particularly 
noticeable in children. While the psychiatric community claims that ADHD is a disorder, 
there are some who approach the disorder from an alternate angle. Chief among these 
is Thom Hartman.  
Hartman, a former psychotherapist, has written extensively on the subject of 
ADHD. He has been involved with establishing schools and daycare centers for ADHD 
children and pioneered the idea that it is a natural phenomenon and possibly a 
biological adaptation from earlier times. He postulated that those who are now 
diagnosed would have been hunters in ancient nomadic and tribal societies and traits 
associated with ADHD would have been useful before pastoral societies began to 
spread and undermine hunting and gathering societies (Hartman, 2003). In Attention 
Deficit Disorder: A Different Perspective, he attempted to reconceptualize the behavioral 
patterns by stating the disorder view of the behaviors and posing the alternate 
interpretation of the hunter child.  
The disorder view holds that those afflicted have a short attention span. 
However, these same individuals can become very focused for extended periods of 
time. The hunter child, in a different framework, constantly monitors its environment for 
new stimuli. The disorder view describes poor planning skills, impulsivity, and 
disorganization while hunter children have the ability to make snap decisions in a 
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positive way, being “able to throw themselves into the chase on a moment's notice” 
(Hartman, 1993, p. 18). The disorder view describes the inability to follow directions; the 
hunter child is conceived as an independent agent. The disorder view describes mind 
wandering and daydreaming; the hunter child is someone who is bored with mundane 
tasks and is stimulated by excitement and new ideas. The disorder view describes 
someone who acts dangerously without considering the consequences; the hunter child 
is willing to accomplish tasks by taking risks. 
Thought patterns among those diagnosed are different as well. The disorder view 
describes a lack of time awareness among these individuals. They believe those with 
the disorder cannot accurately judge how long something will take. Hartman promoted a 
fluid thought pattern and the flexibility to change strategy at a moment's notice. The 
disorder view describes a person who cannot easily make connections between words 
and concepts, believing a learning disability might be present; whereas, Hartman 
described a person with visual and concrete thinking with sight of a goal even if it is not 
converted into language. And finally, the disorder view describes a lack of social graces 
Hartman claimed that if there is work to be done such people do not beat around the 
bush with niceties (pp. 14-18). 
Hartman represents an academic community who question the tenets of the 
therapeutic state. The importance of his view goes beyond raising questions about the 
pathologization of the behaviors; it shows there are qualified academics with extensive 
experience and knowledge about the disorder who disagree with its label. This 
community includes psychologists, psychiatrists, various medical specialists, 
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sociologists, anthropologists, biologists and a host of other academics who choose to 
challenge the current view. 
ADHD is not only debated in the academic community, it has spilled over into the 
larger culture. Lay people are also knee deep in the discussion. Proof of this is reflected 
in popular television and literature. Not only has ADHD been discussed in the news, it 
has appeared in amusing television skits, episodes, and anecdotes as well. 
 
Cultural Impact of ADHD 
ADHD has permeated pop culture, becoming part of the language and crossing 
over from the strictly medical to an everyday word for some people. There are jokes 
about it, television episodes, skits, radio broadcasts, news specials, songs and comic 
strips. Few people today have never heard of the disorder. In literature and popular 
culture, the ADHD character has been around for some time as well. Hallowell and 
Ratey (1994) discussed how forms of the ADHD child have been popular characters in 
the 20th century, citing characters such as Calvin from Calvin and Hobbes and Dennis 
from Dennis the Menace. But the prevalence of such characters in society runs deeper 
than that. The 1908 character Mr. Toad, from Kenneth Grahame’s The Wind in the 
Willows, is another example. Mr. Toad was the self-centered, conceited, impulsive, 
flighty, wealthy owner of Toad Hall who was always being caught up in some new fancy 
or obsession without thinking ahead. He acted regularly on impulse and whim without 
regard for consequences. 
A few older examples that show the prevalence of this behavior in the past would 
include Tom Sawyer from Mark Twain’s The Adventures of Tom Sawyer and other 
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books. Several characters in Lewis Carroll’s Alice’s Adventures in Wonderland fit the 
profile as well, including The White Rabbit and The Mad Hatter. Hallowell and Ratey 
(1994) posed the question, “how is it that this [ADHD character] has existed throughout 
the centuries?” (p. 271).  This implies an acceptance that the behaviors are not new, 
they have only been medicalized. 
In addition to literary examples of the ADHD-like character and the 
aforementioned Saturday Night Live skit, there have been a host of other television 
shows that have dealt with the subject. ADHD is often the object of amusement, mostly 
taking view that the disorder is not real or treatment is handled badly. Steve Carell 
presented a mock report on the disorder on The Daily Show with Jon Stewart. In this 
presentation Carell (2000) introduced the disorder saying: 
Today I want to talk about an illness that's sweeping the nation, Attention-Deficit 
and hyperactivity disorder or what doctors call ADHD. Formerly ADD and before 
that spazzing out. 
According to Carell, symptoms indicating ADHD are “talks too much,” “not seeming to 
listen to parents or teachers,” “fidgeting and restlessness,” “always asks 'Why?',” “points 
out fat people,” “not interested in sex,” “wants his 'mommy',” and “outgrows clothing.” 
The host of the show, Jon Stewart, responded, “it sounds like you just described every 
child in the world” and Carell agreed, “exactly Jon, now the question is how do we make 
them well again?”  
Carell then swallowed fake Ritalin in an amusing manner, listing side effects as 
he ingested. He claimed that every medicine has side effects and told people not to 
worry. At the suggestion that Ritalin might be over prescribed Carell asked, “can you 
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over prescribe happiness?” He furthered, “lithium makes kids happy, Ritalin makes 
parents happy” and “a few pills every four hours or so, no more 'I'm bored Dad' or 'read 
me another story' or 'when's Mommy coming back?' 'Stop drinking!'” (Comedy Central, 
2000). This humor reflects the beliefs of those who think ADHD is linked to bad 
parenting and bad schools.  
The Simpsons (Scully, et al., 1999), a popular cartoon sitcom, directly tackled the 
topic of ADHD and medication. In 1999, the FOX network aired the episode “Brother’s 
Little Helper.” It was a comical exploration of the treatment of ADHD children. Bart 
Simpson, the rambunctious and often troublesome son of Homer and Marge, was 
diagnosed with Attention Deficit Disorder by the principal of his school. He was 
prescribed the fictitious drug Focusyn. When Bart became unstable to the point of 
violence and psychosis, his mother took him off of Focusyn. The episode ended with the 
jingle, “When I can’t stop my fiddlin’ I just takes me Ritalin” (Scully, et al., 1999). 
As these media presentations illustrate, one of the cultural themes regarding ADHD 
often revolve around the medication used in its treatment. There are many medications 
used in treatment. Without an elementary understanding of the history and properties of 
the most popular of these, the weight of events concerning labeling and treating 
America's youth and adults cannot be fully grasped. The term Minimal Brain Damage 
was used to describe active children beforehand in a limited capacity. However, ADHD 
has its roots in the accidental discovery of the current most common type of treatment: 
stimulants.  
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Chapter 3 
Introduction to Stimulant Medication 
 
One of the criticisms of ADHD is that the treatment was discovered before the 
diagnosis itself, leading to speculation that the disorder was created to describe those 
most effected by stimulants. Dr. Charles Bradley's discovery of the effects of stimulants 
on hyperactive children occurred at a time when “psychological response of children to 
drug therapy of any sort [appeared] to have been a generally neglected subject” 
(Bradley, 1937, p. 577). Bradley was a physician at the Emma Pendleton Bradley Home 
in Rhode Island, a residential treatment facility for children who were diagnosed with 
neurological or behavioral disorders (American Psychiatric Association, 1998). He was 
the first to discover the calming effects of stimulants on hyperactive children (Hallowell 
& Ratey, 1994). Bradley’s sample consisted of 21 boys and 9 girls who were 5-14 years 
old. These children were hospitalized for a number of reasons. Bradley (1937) claimed:  
The children’s behavior disorders were severe enough to have warranted 
hospitalization, but varied considerably. They ranged from specific educational 
disabilities, with secondarily disturbed social behavior, to the retiring schizoid 
child on the one hand and the aggressive egocentric epileptic child on the other. 
(p. 578) 
He administered Benzedrine to these children and, observing their behavioral effects, 
was very pleased with the results. 
Bradley (1937) reported that the most “striking change in behavior during the 
next week of Benzedrine therapy occurred in school activities of many of these 
patients,” further asserting, “fourteen children responded in a spectacular fashion” (p. 
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578). Fifteen children improved in school and two children showed no change at all. 
Bradley reported, “Fifteen of 30 children responded to Benzedrine by becoming 
distinctly subdued in their emotional responses”. He contended that several children 
who had “expressed their irritability in group activities by noisy, aggressive, domineering 
behavior” became “more placid and easy-going.” Bradley also admitted there were 
negative side effects; seven of the children “gave evidence of a sense of well-being, 
even to the point of mild euphoria,” three were “observed to cry much more easily,” and 
two “were noted to wear worried expressions quite foreign to their usual appearance.” 
Sleep was disturbed for 6 of these children, a moderate rise in blood pressure was 
noted in half of them, and “loss of appetite and nausea at the time of the morning meal” 
was reported. There were also 8 cases of gastrointestinal distress and one child was 
afraid to go outside and “fearful of death” (pp. 579-581). 
Some children became more talkative and active but Bradley used words like 
“subdued” to describe the effect on many of them. He posited, “20 mg. was generally a 
satisfactory amount to produce changes in behavior without undesirable psychological 
consequences” (p. 581). He concluded: 
To see a single daily dose of Benzedrine produce a greater improvement in 
school performance than the combined efforts of a capable staff working in a 
most favorable setting, would have been all but demoralizing to the teachers, had 
not the improvement been so gratifying from the practical viewpoint. (Bradley, 
1937, p. 582) 
He noted that the subjects who improved in school “were of good intelligence” (p. 582). 
In 1944, seven years after Bradley discovered the positive effects of simple 
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amphetamines on hyperactive children, Ritalin was synthesized (Baughman & Hovey, 
2006). Ritalin, a gentler stimulant than used in the Bradley study, is simply a brand 
name for a commonly prescribed stimulant for ADHD, methylphenidate (Reiff & Tippins, 
2004). The United States Food and Drug Administration approved it for use in 1955 
(Associated Press, 2006). Later, in the 1970s, Ritalin was one of the first drugs to be 
classified as Schedule II (Breggin, 2002), a classification reserved for the most 
dangerous and controlled substances legally available. Other Schedule II drugs include 
Cocaine, Methamphetamine, Morphine, Opium, and OxyContin (DEA). 
In 1971, the FDA and the National Academy of Sciences issued a public warning 
about the abuses of the drug, and by the late 1970s Sweden issued a ban on it based 
on addictive properties and trafficking (DeGrandpre, 1999). The United States 
Government has continued to sanction the use of Ritalin even though it is often 
compared to cocaine. Indeed, in 2001 an article in the Journal of the American Medical 
Association reported that Ritalin was more powerful than cocaine in comparable doses 
(Baughman & Hovey, 2006). There is danger in stimulant use but millions of users 
report improvement in coping with ADHD. While other aspects of the drug are debated, 
the immediate social benefits are not often among the topics. It is undeniable that for 
some people, stimulant use does increase performance in the short term; a plethora of 
scientific articles have concluded this. 
Today there are several stimulants on the market used to treat ADHD. Among 
the most widely prescribed are Ritalin (methylphenidate) and Adderall (d- and l-
amphetamine combination). Ritalin once dominated the market as the treatment for 
ADHD, but Adderall is an alternative treatment. After a multi-million dollar advertising 
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campaign (Baughman & Hovey, 2006), Adderall has passed Ritalin in sales (Gaviria, 
2001). Adderall has been accused of being a repackaging of the banned dietary drug 
Obetrol (Baughman & Hovey, 2006); this is only a rumor. It began being marketed as an 
“improved form of stimulant medication” in the late 1990s and early 2000s but is only a 
chemical mixture of four “old-fashioned” amphetamines that resemble Dexedrine 
(Breggin, 2001, p. 29). It is, in many respects, like Ritalin. It can also be obtained in 
traditional and long-lasting formulas (Shire, 2007). Some claim Adderall is safer than 
Ritalin but it is not. It may even be more harmful to the brain (Breggin, 2002). The 
popularity of Adderall and the ADHD diagnosis is exemplified by the fact that Adderall 
sales brought in $19 million in 1997. The figure rose to $200 million by 2000. By 2002 
Adderall sales represented 40% of Shire's income, bringing in $400 million (Baughman 
& Hovey, 2006). 
Stimulants bear that title because they increase the arousal and activity of the 
brain. While chemically similar, different stimulants may affect individuals differently. If 
one stimulant does not work for someone, it is not uncommon for the physician to switch 
to another. Sometimes more than one stimulant at a time is used (Hallowell & Ratey, 
1994). According to Yale University psychiatrist Thomas Brown (2005), medications 
offer relief from ADHD; they are not a cure, although for some people, stimulants may 
be all they need to treat their ADHD. 
When people are on methylphenidate, they are “turned on” to whatever task 
needs to be performed. Brain scans show increased metabolic activity in the brain that 
corresponds with self reports by patients of increased well-being (Brown, 2005). 
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Stimulants work by blocking dopamine transporters in the brain. According to Brown 
(2005): 
Blocking slows the normal reuptake process so that a larger amount of dopamine 
is held a bit longer at countless synaptic junctions, thereby improving 
communication in those neural networks operating on dopamine. (p. 252) 
This process improves neural signaling for whatever specific task needs to be 
performed, which effectively drowns out “noise” and competing signals. It allows some 
parts of the brain to signal more effectively with others, in effect streamlining the 
efficiency of communication and eliminating distraction. “In other words,” Brown says, 
“increased dopamine in the synapse can act almost as a kind of ‘Viagra’ to encourage 
the brain’s response to the task” (p. 252). 
Hallowell and Ratey (1994), both medical doctors diagnosed with ADHD, 
explained that each dose of normal methylphenidate, no matter the size of the dose, 
lasts about four hours depending on the individual taking the medication. There is also a 
slow release version available that doubles the time it stays in effect. This option is also 
now available in the more popular Adderall. With either type it is common for an 
individual to take multiple doses a day, and almost required with the regular form. The 
dosage is typically about 10 mg three times daily; the type of methylphenidate used 
affects the dosage times. Generally the patient is started out on 5 mg and works up to 
10mg or higher as needed. The patient is monitored and the dosage is manipulated 
based on side effects. The dosage and schedule for methylphenidate use varies from 
person to person. Hallowell and Ratey (1994) explain: 
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Often it takes weeks, even months, to find the right dosage and the right dosing 
schedule. Sometimes a low dose will work, but only if it is given at the right time. 
Sometimes a small increase in dose will make a great difference. Sometimes the 
addition of another medication will allow the first medication to work better, as 
combining a stimulant with an antidepressant or combining a beta-blocker with a 
stimulant. This can be a tedious process, like trying on many pairs of shoes until 
you find the right fit. (pp. 239-240) 
While many doctors have no problem prescribing a drug so subjectively, there is 
considerable controversy. Barkley (2000) partially attributes this controversy as the 
consequence of a fringe religious group’s attack on Ritalin in the 1980s and 1990s. 
Most likely he was referring to the continued attack on psychiatry by the Church of 
Scientology. Many who speak out against ADHD have subsequently been accused of 
being Scientologists, sometimes to the point of having to repeatedly defend their 
positions apart from the Church of Scientology. It has become an easy attack from 
ADHD supporters. Barkley believes the media has also been an instrument of confusion 
for the public, as well as some physicians. He claims: 
Unfounded fear of these drugs is unfortunately perpetuated by some physicians’ 
requirement that parents sign a consent form indicating they have been informed 
about the medicines and their side effects. (Barkley, 2000, p. 271) 
He insists these medicines are safe and encourages parents considering stimulant 
medications for their children to “gather as much background information as you can” 
(p. 269), further saying: 
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The use of these medications for children with ADHD continues to be 
controversial in the public’s mind, although there is absolutely no controversy 
among the scientific community as to the safety and effectiveness of these 
medications. (p. 270) 
This claim may be true among medical and psychiatric organizations like the National 
Institutes of Health and the American Psychiatric Association, where casting votes 
makes decisions and diseases; that is not the case with all medical practitioners. 
As in the lay community, there is a high degree of controversy within the scientific 
community. Many dissenters are psychiatrists and medical doctors who have spent 
decades practicing medicine and doing independent research. Among these is Peter 
Breggin, author of The Ritalin Fact Book. This work claimed to expose facts about 
Ritalin and stimulants that were not widely known to the general public, and even 
among many academic circles. Nicknamed the conscience of psychiatry, Breggin drew 
upon his professional experience as a psychiatrist since 1968 to educate the public on 
the negative side effects of Ritalin as well as other amphetamine and amphetamine-like 
drugs. Opposing views like Barkley’s and Breggin’s typify the discussion of hyperactivity 
since the 1930s, and many of these discussions revolve around the use of stimulant 
medications. Despite what committees and experts say, there is a rather heated 
argument.  
As in most cases, the people on the extreme edges of the continuum are the 
ones with the loudest voice. Lost in this clamor are those cautious takers of the middle 
ground. Lawrence Diller, a practicing behavioral pediatrician and assistant clinical 
professor at the University of California, was interviewed by Jim Lehrer on NewsHour 
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for PBS. He was asked whether he thought Ritalin is “manna from Heaven” or poison. 
Diller responded: 
I think that for the individual child, once you've explored issues of parenting and 
getting the school to work as best with that child as possible, and making sure 
the child doesn't have any learning problems, that if that child is still struggling, 
utilizing Ritalin to allow that child to cope more effectively I think is a legitimate 
avenue. That's my role as a doctor. But my role as a citizen is to ask the question 
why do we use 85 percent of the world's Ritalin? Why have Ritalin use rates 
gone up 700 percent in our country in the last nine years? (Lehrer, p. 2) 
Some say that the drugs are the problem, others say abuses of the drugs, and 
still others indicate flaws inherent in the medical and psychiatric communities. Either 
way, there has to be a reason why the United States consumes five times more 
methylphenidate than any other country in the world (Gaviria, 2001). A closer look at the 
history of the disorder will shed some light on the issues. The early years of the 
diagnosis from 1902 through the 1960s laid the foundation for the conceptualization of 
what we now recognize as a disorder. The amount of research on the subject increased 
exponentially during the first half of the 20th Century. Economic and political factors 
influenced the development of the diagnosis as well as the increased interest by lay 
people. Chapters 4 through 8 discuss, in chronological order, the rise of the disorder. 
They demonstrate the process whereby ADHD was birthed and nurtured within the 
therapeutic state. They also exemplify the process of medicalization as happened with 
the disorder. 
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Chapter 4 
A Social History of ADHD: 1902 Through 1969 
 
Though the first reference to behaviors now associated with ADHD was made in 
1798 by Alexander Crichton (Palmer & Finger, 2001), the first reference of note to 
ADHD-like behaviors was made by Dr. George Fredrick Still in 1902 during an address 
to the Royal College of Physicians in London (Zimmerman, 1999). Still, a pediatrician, 
described a predominantly male group “who were defiant, excessively emotional, 
passionate, lawless, spiteful, and had little inhibitory volition”. All had displayed these 
symptoms before they were 8 years old (Hallowell & Ratey, 1994, p. 271). Still referred 
to his male subjects as “Fidgety Phils” (Zimmerman, 1999).  
After careful inspection of the children’s families, Still reported, while they were 
raised in good homes, the children had a history of other disturbances in the family such 
as depression, alcoholism, and conduct problems. On the basis of this information, he 
concluded that the children’s hyperactive and deviant nature had to be based on 
biology. Still diagnosed the children with Minimal Brain Damage. He made the 
assumption that since brain damage can cause behavioral abnormalities, and these 
children were raised in good homes, their brains must be damaged in some way 
whether by an accident or by birth (Baughman & Hovey, 2006). His findings were later 
published in Lancet, the esteemed British medical journal (Zimmerman, 1999).  
It was not seen as a pressing issue and thirty years passed before another 
significant publication was released on hyperactivity. Since Still’s publication in 1904, 
there was an apparent increase in either childhood hyperactivity, or the observance 
thereof. This prompted Kahn and Cohen to publish a piece in the New England Journal 
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of Medicine called “Organic Driveness” in 1934. They were concerned with discovering 
a biological basis for hyperactivity. Picking up where Still left off, they proposed that the 
recent spike in hyperactive children was due to the encephalitis outbreak in 1917-1918. 
This outbreak had been known to cause other strange neurological conditions such as 
insomnia, poor impulse control, and impaired attention. While it is no longer believed 
that ADHD is caused by encephalitis, Kahn and Cohen were the first to link these 
specific symptoms to Minimal Brain Damage (Hallowell & Ratey, 1994). It was only 
three years after the publication of this article that Charles Bradley accidentally 
discovered the effects of stimulants on hyperactive children in his hospital. In 1950, 
Bradley performed another study that, like his initial research, indicated stimulants 
effectiveness in treating hyperactivity (Baughman & Hovey, 2006). Since there had 
previously been next to no medical discussion of the topic, this is clearly the point that 
ADHD had its initiation into popular medical literature.  
Stimulant medication was seen as a useful tool for many ailments and a few 
years later, in 1944, Ritalin was synthesized in what Diller (1998) calls an unsuccessful 
attempt to create a stimulant without addictive properties and could be increasingly 
tolerated. Soon after the Drug Enforcement Administration approved Ritalin as well as 
Dexedrine, the amphetamine used in Bradley’s initial research, for use with the general 
public (Breggin, 2002). The 1957 Physician’s Desk Reference stated Ritalin was to be 
used for: 
Chronic fatigue and lethargic and depressed states, including those associated 
with tranquilizing agents and other drugs; disturbed senile behavior; 
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psychoneuroses and psychoses associated with depression; and in narcolepsy. 
(Morton & Stockton, 2000, p. 159) 
While stimulants arouse the depressive and lethargic patients, they stimulate 
hyperactive children in a different way. Because of its reverse effects, Ritalin was 
quickly prescribed as the drug of choice for treating Minimal Brain Damage. 
The 1950s was a season for rapid growth and change in the field of psychiatry. In 
1952 the first edition of the Diagnostic and Statistical Manual for Mental Disorders was 
published by the American Psychiatric Association. While significant, the document did 
not mention ADHD (DSM-I, 1952). Five years later a Providence psychiatrist, Maurice 
Laufer, and his colleagues “announced the discovery of a new syndrome: hyperkinetic 
impulse disorder” (Schrag & Divoky, 1975, p. 42). In an article published in 
Psychosomatic Medicine in 1957, they tried to match his new syndrome with a 
dysfunction in the thalamus, a structure in the mid-brain.  
Their work, which included many of the symptoms now associated with ADHD, 
was a major step towards centering on the condition. A noteworthy inclusion was the 
belief that hyperkinetic impulse disorder was a rare syndrome, occurring in 1 in every 
2,000 individuals (Laufer, et al., 1957). This was far from the virtual epidemic ADHD is 
now. At this point, there were varying descriptions of what appeared to be the same 
animal; one that may or may not be a new phenomenon but certainly one increasing in 
frequency. Because these behaviors were documented in the 18th Century, this was an 
old set of behaviors gaining increased attention from the medical community. Moreover, 
it coincided with the beginning of the therapeutic state.  
 32 
Because the nature of medicine, society, and deviance was changing, the 
medicalization of hyperactivity was just part of the increased medical attention given to 
well known phenomena. On June 7, 1955, The Committee on Public Health of the New 
York Academy of Medicine issued a Report on Drug Addiction. In this report they said 
there needed to be “a change in attitude toward the addict who is to be looked on as a 
‘sick person, not a criminal’” (Drug Addiction, 1955, p. 67). Instead of punishment, 
mental health treatment and psychopharmacology became more commonplace. By the 
latter half of the 1950s, the foundations of psychiatric diagnosis were becoming well 
established; mental hygiene was becoming a serious issue. A 1957 edition of Science 
contained an article called “Drugs for the Soul: The Rise of Psychopharmacology” that 
dealt with the recent rise of prescriptions for mental disorders. The psychiatric 
establishment was growing in power and prestige but prior to the 1960s there was still 
limited mention of hyperactivity as a disorder (DeGrandpre, 1999). It was, however, 
obviously seen as a growing problem. 
The 1960s brought an increased discussion of Minimal Brain Damage, also 
popularly known at the time as Hyperactive Child Syndrome. Early that decade the 
syndrome was conceived as biological rather than a consequence of brain damage 
(Hallowell & Ratey, 1994). The disorder became popular enough that in 1961 the FDA 
approved Ritalin for use specifically with children (Baughman & Hovey, 2006). This 
opened the proverbial Pandora’s Box; a whole new segment of the population could 
now consume Ciba’s product. For the next 10 years Ciba marketed Ritalin for a number 
of uses in various journals. By this time, there were several studies showing the 
immediate positive benefits of stimulant medications for the treatment of child 
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hyperactivity. Being able to market immediate relief for parents and teachers with hard-
to-control children was profitable for the drug manufacturer. The era was rife with 
change and child learning disabilities became a cause for concern for many parents. In 
January 1964, the Association for Children with Learning Disabilities was founded 
(Crawford). An example of changing attitudes of the time can be seen in that a few 
years later a survey of the entire school system of Des Moines revealed that teachers 
believed 53% of the boys and 30% of the girls displayed problems with overactivity in 
the classroom (Schrag & Divoky, 1975). With growing focus on childhood disorders and 
learning disabilities, professionals and laypersons began to take notice of hyperactive 
children.  
Mid-decade, efforts were made to medically congeal the diagnosis. Schrag and 
Divoky (1975) explain: 
In what was to become a key document establishing the new disease and 
converting unacceptable behavior into a medical ailment, a team of national 
authorities headed by Sam D. Clements of the University of Arkansas Medical 
Center published a monograph in 1966 which purported to eliminate 
“professional disjunction and discord.” (p. 43) 
Clements’ group of experts was supported by the National Institute of Neurological 
Diseases and Blindness (part of the Public Health Service) as well as the Easter Seal 
Research Foundation. They spent two years researching 38 separate terms 
representing Minimal Brain Dysfunction before publishing their findings (Clements, 
1966). The study was the result of professional dissatisfaction with the 1952 DSM’s lack 
of usefulness in treating children. The professional community was not the only one 
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interested in such a study because “stirrings of discontent have been intensified by 
parents of such children” (p. 1). The advice offered in Minimal Brain Dysfunction in 
Children was that MBD was of so much concern that society could no longer “afford the 
luxury of waiting until causes can be unquestionably established by techniques yet to be 
developed” (Schrag & Divoky, 1975, p. 44). In effect, the researchers believed the issue 
so serious they felt justified in defining and treating this disorder in the absence of a 
concrete biological connection. They concluded that those who suffered from Minimal 
Brain Dysfunction met a vague set of qualifications. The children were said to be: 
Of near average, average, or above average general intelligence with certain 
learning or behavioral disabilities ranging from mild to severe, which are 
associated with deviations of function of the central nervous system. These 
deviations may manifest themselves by various combinations of impairment in 
perception, conceptualization, language, memory, and control of attention, 
impulse or motor function…These aberrations may arise from genetic variations, 
biochemical irregularities, prenatal brain insults or other illnesses or injuries 
sustained during the years which are critical for the development and maturation 
of the central nervous system, or from unknown causes. (Schrag & Divoky, pp. 9-
10) 
Further clarifying the disorder, Clements (1966) listed 99 more indicators along 
with classic hyperactive and disobedient symptoms. These included: “spotty or patchy 
intellectual deficits,” “achievement low in some areas; high in others,” “distorted concept 
of body image,” “few, if any, apparent gross abnormalities,” “general awkwardness,” 
“slowness in finishing work,” “easy fatigability,” “thumb-sucking, nail-biting, head-
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banging, and teeth-grinding,” “slow toilet train,” “sleep abnormally light or deep,” 
“socially bold and aggressive,” “possibly antisocial” and “physically immature, or 
physical development normal or advanced for age” (pp. 11-13).  
The importance of these symptoms can be seen in that the diagnosis has 
remained guesswork. Though the Clements document could be applied to virtually any 
child, it provided a legitimization for a disorder that many parents and teachers were 
concerned about; a moral consensus reminiscent of the therapeutic state. Child 
psychiatry was thriving and concern for children’s learning disabilities eventually 
resulted in the creation of the Journal of Learning Disabilities in 1967 (Schrag & Divoky, 
1975).  
The diagnosis finally received sanction from The American Psychiatric 
Association with the release of the second edition of the Diagnostic and Statistic Manual 
of Mental Disorders in 1968. The DSM-II added 51 new disorders to the catalogue 
including a brief passage describing the Hyperkinetic Reaction of Childhood (or 
adolescents). The DSM-II (1968) stated the disorder was: 
Characterized by overactivity, restlessness, distractability, and short attention 
span, especially in young children; the behavior usually diminishes in 
adolescence. If this behavior is caused by organic brain damage, it should be 
diagnosed under the appropriate non-psychotic organic brain syndrome. (p. 50) 
Although vague, the entry constituted an official diagnosis. Changing the term from 
Minimal Brain Damage to Hyperkinetic Reaction of Childhood served to lessen the 
stigma of the diagnosis. This new label did not, however, stop the term Minimal Brain 
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Damage from being used. As late as 1987 Minimal Brain Dysfunction (MBD) was being 
used in discussions of learning-disabled children (Coles, 1987).  
According to Conrad (2005), medicalization takes place with the expansion of the 
“power and authority of the medical profession” (p. 4). As late as World War II, doctors 
were still widely regarded as butchers because medical science was still very much 
guesswork. However, with the modern advances in science the medical community took 
many conditions under its sphere of influence; hyperactivity in children was one of 
these. This was spurred on by medical professionals trying to distinguish themselves in 
a cutthroat field. When professionals compete “for authority in defining and treating 
problems” medicalization takes place (Conrad, 2007, p. 9). Doctors, with the latest 
technology, were looking for new disorders, diseases, and illnesses. Numerous mental 
disorders and learning disabilities were voted into existence. From its inception through 
the 1960s, ADHD had been largely promoted by individuals in the medical and 
psychological communities. In the 1970s the medicalization of ADHD will change. It will 
be a time of radical transformation in the conceptualization of the diagnosis. With the 
advances in the 1960s to spur it on, the 1970s paved the way for the solid 
establishment of the disorder.  
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Chapter 5 
A Social History of ADHD: 1970 Through 1979 
 
While it was originally suggested that Minimal Brain Damage could affect 1 in 
2000 children, an estimated 150,000 children were being medicated with Ritalin in the 
early 1970s (Diller, 1998). The concern over hyperactivity in children was somewhat 
common; the medical and psychiatric communities were gaining enormous influence. 
The rise of ADHD corresponded with the rise of numerous learning disabilities. During 
the early 1970s, anomie regarding childhood mental illness was widespread. There was 
little known about them and learning disabilities were becoming commonplace in 
schools where they had not been before. Schrag and Divoky (1975) reported: 
As early as 1971, William M. Cruickshank of the University of Michigan, a 
national authority in special education, had complained that the [learning 
disability] label was being applied to children who stuttered, teased the family cat, 
had night terrors, couldn't swim, masturbated, didn't like to go with girls, bit their 
nails, had poor eating habits, didn't keep their rooms neat, wouldn't take baths, or 
didn't brush their teeth. (p. 47) 
Adding fuel to the fire, the U. S. Department of Health, Education, and Welfare 
released a report estimating that 3% of school aged children had hyperkinesis. As a 
consequence of this pronouncement, public concern grew even more. The Government 
began to spend enormous sums of money on social services. Between 1966 and 1972 
money spent on the handicapped and mentally disabled in public schools tripled 
(Schrag & Divoky, 1975). 
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There were many inquiries into hyperactivity during the 1970s. Understandably, 
many of these were in support of the increasingly popular childhood disorder. A fringe 
theory, still popular among some, was introduced that attempted to conceptualize 
hyperactivity, along with other mental disorders, as a nutritional deficiency (Reiff & 
Tippins, 2004). While unproven, many nutritionists and those with organic sensibilities 
still cite this as a possible cause for hyperactivity. Several studies pointing to various 
causes arose with varying success; however, a very popular explanation came from the 
1970 Kornetsky study. Kornetsky proposed a Catecholamine Hypothesis of 
Hyperactivity. Hallowell and Ratey (1994) explained: 
Catecholamines are a class of compounds that includes the neurotransmitters 
norepinephrine and dopamine. Since the stimulants affect norepinephrine and 
dopamine transmitter systems by increasing the amount of these 
neurotransmitters, Kornetsky concluded that symptoms of ADD possibly was 
caused by an underproduction or underutilization of these transmitters. (p. 274) 
In other words, the hyperactive brain does not produce enough dopamine transmitters 
and stimulant medications increase production of these. This is a widely cited study in 
support of the diagnosis; however, as impressive as this theory sounds, science has yet 
to provide a link between catecholamines and ADHD (Hallowell & Ratey, 1994).  
The Kornetsky study was one of many in support of stimulants for use in treating 
hyperactivity. Also noteworthy was a 1978 study of identical twins. The researchers, 
Cunningham and Barkley, found that children on stimulants spent more time playing 
alone and less time initiating social contact with other children. Though human beings 
are social in nature, this was seen by some as a positive result (Breggin, 2001). There 
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was no shortness of studies in support of the use of stimulants for immediate control of 
children; however, dissenting voices were present. 
In 1976, Herbert Rie, professor of Pediatrics and Psychology at Ohio State 
University, and his colleagues reported that on the basis of a two year comprehensive 
study of Ritalin that it actually interferes with learning. This contradicted the widely held 
belief that Ritalin improves school performance. In a double blind study, Rie and 
colleagues found that even when the child had reportedly improved behaviorally in a 
school environment there was no actual improvement in academic ability. According to 
the researchers, teachers often reported better scholastic achievement while in reality 
there was none. This is a natural result of subjective learning techniques. The study 
concluded that giving medications for learning disabilities was not effective (Breggin, 
2001). In a 1975 mid-study interview with Schrag and Divoky, Rie discussed what would 
have been the current findings of the ongoing study. Schrag and Divoky (1975) 
reported: 
At first the teacher ratings indicate an improvement, Rie told us, because “the 
kids slow down dramatically and are out of people's hair, but when objective 
testing is done, they're not performing one bit better. In fact, what we're 
observing on this round of measurement is that the youngsters on drugs are far 
less responsive and enthusiastic, and are far more apathetic, humorless, and 
zombie-like. It's there and you can see it and measure it, and we don't know why 
it hasn't been picked up before.” (p. 89) 
Furthering the argument against stimulant medications, in 1977, a Norwegian team 
found that Ritalin affected growth hormones, effectively stunting the growth of children 
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who take them (Breggin, 2001). This is still a discussion topic regarding the use of 
stimulants on children.  
While stimulants were a popular topic, there were studies that did not employ 
their use. In 1971, Coleman publicized the results of a study of hyperactive children in 
the Journal of Pediatrics that emphasized the social nature of the diagnosis. In 
“Serotonin Concentrations in Whole Blood of Hyperactive Children” Coleman studied 
serotonin levels in the brains of over 25 hyperactive kids. Using a control group of 
similar kids without the hyperactivity, he found that the serotonin levels in the 
hyperactive children were much lower than those in the normal children; so low that the 
lowest serotonin level in the non-hyperactive children was still higher than the highest 
serotonin level in the hyperactive children. DeGrandpre (1999), remarking on this study, 
claimed if it were to happen now the researchers would see this as proof that ADHD “is 
the result of some inborn biological disorder” (p. 145). However, this was not the 
conclusion drawn. Coleman took two of the most hyperactive children, and effectively 
“cured” them of their hyperactivity, if only for a short time.  
Coleman placed the two most hyperactive children in completely different 
environments, in this case, the research hospital. When the children were taken out of 
their homes, their serotonin levels slowly came up and the hyperactivity went down. 
They were subsequently returned. After they spent only a month back in their homes, 
their serotonin levels had, yet again, dropped and their hyperactivity increased. While 
this study does not prove or deny the claim that ADHD is a real disorder, it did illustrate 
a marked difference in hyperactivity levels in different environmental settings with 
corresponding chemical brain changes. It indicated an environmental orientation for 
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hyperactivity. The problem was shown to not be an inherent brain dysfunction or 
disorder. This is one of the most important studies indicating social orientation to this 
phenomenon (DeGrandpre, 1999). 
While the Coleman study raised questions about the use of stimulants, a 1973 
article that appeared in the New England Journal of Medicine raised questions about 
the hyperactive label itself. Based on an extensive review of the literature surrounding 
the use of stimulant medications on those diagnosed with Minimal Brain Damage, the 
study concluded that the reasoning behind the establishment and continuation of the 
diagnosis of Minimal Brain Damage was circular. Many of these studies had assumed 
that the symptoms of the disorder were caused by brain damage, thus leading to a 
diagnosis of brain damage based solely on the presence of the symptoms (Schrag & 
Divoky, 1975, Breggin, 2001). In effect, researchers had claimed these children had 
brain damage because they were hyperactive, and that they were hyperactive because 
they had brain damage. 
During this period Ciba, the makers of Ritalin, was very active. They manipulated 
public confusion with gusto, marketing Ritalin for Minimal Brain Dysfunction as well as 
depression, alcoholism, schizophrenia, tired mother’s syndrome, and an energy boost 
for the elderly. Schrag and Divoky (1975) claimed: 
Through the late sixties and early seventies, the CIBA literature was backed by a 
direct sales campaign in which company representatives were urged, in the 
words of one CIBA executive, to become ‘more effective pushers.’ The objectives 
were teacher training institutes, juvenile probation officers, PTA meetings and 
whatever other community groups might be hospitable. ‘Your ingenuity in the 
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promotion of Ritalin,’ the executive said in his 1971 territorial sales report, ‘is 
becoming more apparent.’ (p. 91) 
This advertisement occurred while the FDA and the National Academy of 
Sciences “warned strenuously of the risks of abuse” indicating the toxicity and addictive 
nature of the substance. This warning was issued, in part, as a response to Sweden's 
banning of Ritalin in the late 1960s (DeGrandpre, 1999, p. 153). In an attempt to control 
the flow of such dangerous substances, early in the decade The Controlled Substances 
Act illegalized and classified a number of drugs by schedule (DEA). A Schedule II 
classification was assigned to those drugs considered the most dangerous. Ritalin, 
along with other amphetamines, was among the first of these drugs to be listed as 
Schedule II.  
While this restricted the sale of the drug, that is as far as it went. Soon after, the 
U.S. Government instructed Ciba to stop marketing Ritalin directly to the public. Ciba, in 
a tactical switch, produced a 96-page document called the Physician’s Handbook: 
Screening for MBD. It was a handbook designed to help doctors better diagnose 
Minimal Brain Damage. The only diagnostic criteria for MBD included in Ciba's 
handbook were results from the 1966 Clements study of hyperactive children (Schrag & 
Divoky, 1975). These results were 7 years old and produced vague and conflicting 
results. Also, the terms Minimal Brain Damage or Minimal Brain Dysfunction were out of 
date; the DSM had already replaced those terms. 
Even with the obstacles placed in front of the company, Ciba was profiting 
enormously from Ritalin. Although Cylert was created as an alternative in 1974 
(Breggin, 2001), Ritalin had already become established as the drug of choice for 
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children needing pediatric stimulants. Ciba continued to run advertisements in medical 
journals. Schrag and Divoky (1975) reported: 
In the previous six years, while the prescription of such drugs has been growing 
at a rate approaching 50 percent a year, tripling between 1970 and 1974, 
Ritalin's share of the market, currently estimated at $30 million annually, grew 
from about 50 percent to something over 80 percent. (p. 89) 
The opinions from professionals, recommendations from teachers, and 
advertisements of drug companies had convinced the public that a plague of 
hyperactive children, heretofore unseen, had been unleashed. Conveniently the cure 
was discovered before the epidemic manifested. Treatment was given without solid 
scientific evidence to support any sort of brain damage. As the decade came to a close, 
the DEA banned the use of the diagnostic label Minimal Brain Damage on the basis that 
it was not scientific (Baughman & Hovey, 2006).  
Previous to the 1970s the medicalization of ADHD had taken place in the 
doctor’s office. In the 1970s, however, parties that had something to gain became more 
active in the process, creating confusion among doctors and lay people alike. Individual 
researchers and doctors were responsible for further medicalization of the disorder in 
the 1970s, but by this time it had crept into society as well. This is evidenced by the fact 
that the U. S. Government had so much involvement; this was done partially in 
response to public confusion. This effectively lent credibility to the disorder, further 
fanning the flames. In the background, Ciba championed the diagnosis by directly and 
indirectly promoting their medication and offering information on the disorder that was 
out of date. As the power and prestige of the medical community grew, so did that of the 
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pharmaceutical companies. One of the more important aspects of medicalization is that 
often it is done without regard for public safety. This can clearly be seen in the actions 
of Ciba. 
During the 1980s, medicalization of ADHD continued in this manner. The decade 
began with a new concept of the disorder, and a new name, putting it on the map as 
one of the most expansive non-terminal medical phenomena in history. Chapter 6 
discusses the developments with the disorder during the 1980s. It outlines the change 
in diagnosis from minimal brain dysfunction (or damage) to Attention Deficit Disorder in 
1980, the transformation from Attention Deficit Disorder to Attention-Deficit/Hyperactivity 
Disorder, and the creation of Children and Adults with Attention Deficit/Hyperactivity 
Disorder, the ADHD advocacy group that would play a key role in establishing a 
diagnosis of ADHD in adults. 
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Chapter 6 
A Social History of ADHD: 1980 Through 1989 
 
The 1980s were a landmark decade for the establishment of a hyperactive 
diagnosis in children. With the rapid acceptance of the disorder in children in the 1970s, 
the 1980s began with 350,000 diagnosed cases (Baughman & Hovey, 2006). A flurry of 
information became available on the subject because it was receiving a significant 
amount of academic and public attention. One theory attempted to link ADHD and other 
learning disabilities to a chronic yeast (candida) infection. While some nutritionists 
subscribe to this theory it never gained widespread acceptance; however it illustrated a 
continued effort to discover scientific support for the diagnosis. A few years later an 
argument was advanced that there was a decreased blood flow in the frontal lobe of the 
brain among ADHD individuals. This theory received more academic support. According 
to Hallowell and Ratey (1994): 
The right hemisphere generally controls the so-called executive or decision 
making capabilities, our visual-spatial abilities, and our ability to process many 
sources of stimuli simultaneously. Some specific deficits associated with right-
hemisphere dysfunction include topographagnosia (getting lost a lot!) and socio-
emotional learning disabilities. (p. 276) 
There have been many subsequent studies into this specific phenomenon with mixed 
results and still no definitive proof.  
Shortly thereafter, in a variation on this theme, the frontal-lobe hypothesis was 
given new life by the assertion that ADHD was the result of the brain’s inability to inhibit 
itself effectively. Presumably this was due to “disturbed inhibition in the cortex” and 
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without this inhibition the brain “fails to block inappropriate responses and fails to send 
out appropriate inhibitory messages” (Hallowell & Ratey, 1994, p. 276). The conclusion 
drawn was that without the inhibition, the brain was not able to tell the individual to put 
on the brakes, resulting in impulsivity and hyperactivity. This has become one of the 
most popular biologically based explanations. 
While many in the medical community were supportive, there was hardly 
consensus. A growing concern among many was that children were being medicated 
too often. Two researchers at the Western Psychiatric Institute and Clinic (Pittsburgh) 
found that two-thirds of children being hospitalized had been treated with multiple 
psychotropic medications prior to hospitalization. Seeing the prevalent use of psychiatric 
drugs in American society, they cautioned: 
Inappropriate and injudicious use of psychoactive medications may be 
associated with unanticipated adverse behavioral effects, which can result in the 
deterioration of a child’s functioning. (Breggin, 2002, p. 34) 
Their warnings went unheeded, but their cautionary note was shared by others.  
A 1986 study indicated that long-term use of stimulants such as Ritalin may 
cause brain damage. CT scans of twenty-four males with a history of hyperkinesis and 
who had been treated with stimulants found that over half of them had brain atrophy. 
This suggested that the atrophied brain damage might be the long-term side effect of 
stimulant use (Baughman & Hovey, 2006). This should have been a warning to those 
who would perform cognitive tests on those who have been treated with stimulants for 
an extended period of time. If the biological evidence for ADHD was brain damage, why 
had the scientific community performed tests on those who had been on stimulants for 
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long periods of time when stimulants were known to cause brain damage? This, in 
effect, leads to cyclical reasoning for the existence of the disorder. Despite the 
questions raised, the decade saw the rapid expansion of ADHD. While scientific studies 
and articles furthered the diagnosis, the most important agents of medicalization came 
from the American Psychiatric Association’s diagnostic bible itself. 
In 1980, the American Psychiatric Association published a new edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-III); a whopping 493-page 
handbook. Enormous compared to the previous editions, it reflected the vast expansion 
in psychological disorders and learning disabilities in the late 1960s and 1970s. 
Coincidentally, after the abolition of the Minimal Brain Damage diagnosis, the DSM-III 
changed the name of the disorder from the vague Hyperactive Reaction of Childhood 
(or Adolescence) to the more scientific sounding Attention Deficit Disorder. The new 
nomenclature came with 4 pages of information compared to the DSM-II’s two 
sentences on Hyperactive Reaction of Childhood (or Adolescence).  
Constructed almost from scratch, as opposed to building upon the DSM-II, the 
new version attempted to pull together all the diagnoses previously attributed to 
hyperactive and inattentive children. The DSM-III (1980) stated: 
In the past a variety of names have been attached to this disorder, including: 
Hyperkinetic Reaction of Childhood, Hyperkinetic Syndrome, Hyperactive Child 
Syndrome, Minimal Brain Damage, Minimal Brain Dysfunction, Minimal Cerebral 
Dysfunction, and Minor Cerebral Dysfunction. In this manual Attention Deficit 
Disorder is the name given to this disorder, since attentional difficulties are 
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prominent and virtually always present among children with these diagnoses. (p. 
41) 
This diagnostic manual made great strides in trimming the symptoms that had 
previously been associated with the disorder. The DSM-III (1980) listed two subtypes of 
ADD, Attention Deficit Disorder with Hyperactivity, and Attention Deficit Disorder without 
Hyperactivity, but acknowledged, “it is not known whether they are two forms of a single 
disorder or represent two distinct disorders” (p. 41). In addition, a subtype was reserved 
for those “individuals once diagnosed as having Attention Deficit Disorder with 
Hyperactivity in which hyperactivity is no longer present, but other signs of the disorder 
persist” (p. 41). Arguably, the most important information in the introduction was this 
admission of ignorance. Seventy-six years of intermittent study had produced an 
authoritative document of uncertainty.  
The DSM-III asserted that the most significant markers of the illness were 
“developmentally inappropriate inattention, impulsivity, and hyperactivity.” Children 
diagnosed with ADD were described as fidgety and restless. They were also said to 
behave as if “running like a motor” (p. 41). Unscientific terms like “on the go” and 
“running like a motor” were part of the actual diagnostic criteria (p. 44). The manual also 
contended that symptoms of ADD were highly variable according to circumstance: 
A child’s behavior may be well-organized and appropriate on a one-to-one basis 
but become dysregulated in a group situation or in the classroom; or home 
adjustment may be satisfactory and difficulties may emerge in school. (DSM-III, 
1980, p. 42) 
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There is perhaps no clearer indication of the social nature of the disorder. According to 
the DSM, ADD manifests itself most prominently in two of the most important agents of 
socialization: the school and home. The authority figures in these environments teach 
children how they are expected to behave in society; they are places where children 
learn to become subservient to the demands of the culture.  
Although the DSM-III noted that, in the home, the ADD child may have difficulty 
following parental instructions or sustaining activities. Discussion of children in the 
classroom was primarily featured. It had long been pointed out that school officials have 
diagnosed ADD before doctors and mental health professionals get a chance. The 
DSM-III lent credibility to this claim saying the disorder frequently “does not come to 
professional attention until the child enters school” (p. 42). In the classroom, signs of 
ADD were inattention, problems with organization and sloppy and/or unfinished work. 
The DSM-III (1980) claimed children “give the impression that they are not listening or 
that they have not heard what they have been told”; and when given 
Individually administered tests, careless, impulsive errors are often present. 
Performance may be characterized by oversights, such as omissions or 
insertions, or misinterpretations of easy items even when the child is well 
motivated, not just in situations that hold little intrinsic value. (p. 41) 
In addition to the primary symptoms, the manual listed the following “associated 
features” for ADD: “obstinacy, stubbornness, negativism, bossiness, bullying, increased 
mood lability, low frustration tolerance, temper outbursts, low-self esteem, and lack of 
response to stimuli” (p. 42). Judging from the disproportional concern with children’s 
academic performance, it might be reasonable to surmise that ADD children manifest 
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these symptoms more often at school. This is not surprising since the structure of 
schools requires discipline and self-regulation. 
Finally, the DSM-III (1980) claimed 3% of the population may suffer from ADD 
but admitted that: 
Nonlocalized ‘soft’ neurological signs, motor-perceptual dysfunctions (e. g., poor 
eye-hand coordination), and EEG abnormalities may be present. However, in 
only 5% of cases is Attention Deficit Disorder associated with a diagnosable 
neurological disorder. (p. 42) 
This is an erudite and elusive way of saying there are no diagnostic tests to measure 
ADD and no genetic markers to indicate its presence. In effect, one cannot prove it even 
exists. It is simply a cluster of behaviors assumed to be a disorder. The addition of ADD 
to the DSM was the single biggest step in solidifying the disorder’s place in American 
culture. Its significance cannot be overstated; and only 7 short years later it was 
expanded.  
In May, 1987 the first printing of the American Psychiatric Association’s revised 
third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III-R) 
was released. While 120,000 copies of the DSM-III were published in 1980, 230,000 
copies of the DSM-III-R were published in 1987. The DSM-III-R was noticeably bigger, 
reflecting the development of the psychiatric movement. The most obvious change in 
the diagnosis was the name; Attention Deficit Disorder was replaced with Attention-
Deficit Hyperactivity Disorder. The most powerful example of the social influence of the 
Attention Deficit Disorder label is the fact that it is still used while the nomenclature has 
been invalid since 1987. There are still academic books and articles published on ADD. 
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Adding to the confusion, experts deviate from the DSM definition of the disorder, at 
times adding a distinction between the two (Barkley, 2000) where one does not officially 
exist. 
The most notable descriptive changes in the DSM-III-R (1987) were nouns and 
language; the designation “people” (p. 50) instead of “children” (1980, p. 42) to indicate 
sufferers was a substantial change and marked a shift in the perception of the 
diagnosis. While the whole entry is vague, for the first time the DSM was nebulous on 
age as well. The document primarily dealt with locations where children are socialized, 
and this was continued in the DSM-III-R with some additions. The new version claimed, 
“Manifestations of the disorder usually appear in most situations, including at home, in 
school, at work, and in social situations” and described symptoms that may occur in the 
“classroom or workplace”. Furthermore, worsening symptoms could occur not only in 
the classroom and while performing chores at home, but also when “attending 
meetings” (DSM-III-R, 1987, p. 50). 
The DSM-III-R offered “an inability to play quietly and regulate one’s activity to 
conform to the demands of the game” as a symptom. It also indicated that “signs of the 
disorder may be minimal or absent when the person is receiving frequent reinforcement 
or very strict control” (p. 50). This language strikingly illustrated that the diagnosis was a 
mechanism to classify and thus facilitate the treatment of a deviant behavioral pattern 
and enforce societal norms through the use of therapy as social control. 
Indications of ADHD were expanded in the DSM-III-R (1987) to include such 
things as “blurting out answers to questions before they are completed, making 
comments out of turn,” and “failing to await one’s turn in group tasks.” Also, at home 
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“interrupting or intruding on other family members” would indicate its presence (p. 50). 
These are all social faux pas but fall short of indicating brain dysfunction. The DSM-III-R 
also chronicled self-harming behaviors like “grabbing a hot pan from the stove” and 
“riding a skateboard over extremely rough terrain” (p. 50), thus implying that diagnosing 
and treating these “people” is actually good for them. This attitude reflects ideals of 
parens patrie; that the medical community knows what is best for the patient when the 
patient does not.  
While the DSM-III-R (1987) left age somewhat open to interpretation by 
substituting “people” for “children” and including discussion of symptoms in a work 
environment, it did not directly discuss adults with ADHD in the indications. In the 
section called Age-Specific Features, variability of symptoms at different ages is 
discussed. The DSM-III spoke of preschool children, older children, and adolescents but 
notably lacked any mention of adults with ADHD. In fact, the only mention is a later 
statement suggesting, “follow-up studies of clinical samples indicate that approximately 
one-third of children with ADHD continue to show some signs of the disorder in 
adulthood” (p. 51). While the text did not specify that adults can suffer from ADHD, it 
paved the way for the medicalization of hyperactive and inattentive traits in adults. The 
exclusion of an adult diagnosis of ADHD in the new edition of the DSM did not stop 
some individuals from taking the next step. By this time, there was speculation that 
children did not age out of ADHD. 
A few months after the DSM-III-R was released, Children and Adults with 
Attention-Deficit Hyperactivity Disorder (CHADD) was founded “by a small group of 
parents of children with AD/HD and two treating psychologists in Plantation, Florida 
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(near Miami).” CHADD claims “these parents came together because they felt frustrated 
and isolated, and there were few places to turn for support and information about 
AD/HD” (p. 9). According to the organization’s website, it was created 
To provide a support network for parents and caregivers; to provide a forum for 
continuing education; to be a community resource and disseminate accurate, 
evidence-based information about AD/HD to parents, educators, adults, 
professionals, and the media; to promote ongoing research; and to be an 
advocate on behalf of the AD/HD community. (CHADD, p. 10) 
The mission statement was simply, CHADD CARES; cares being an acronym for 
collaborative leadership, advocacy, research, education, and support (CHADD). 
The significance of CHADD was multi-layered. When the American Psychiatric 
Association would not make the leap from the childhood disorder ADHD to adults with 
ADHD, CHADD did. That is not to say they focused on adults with ADHD; their primary 
goal was regarding support and information for parents and caregivers who have 
children with the disorder. However, CHADD played a key role in extending the 
diagnosis and advocating the idea that ADHD was not just a childhood disorder. It is 
inherent in the name Children and Adults with Attention-Deficit Hyperactivity Disorder 
that they began with the belief that adults suffer from this as well as children.  
Conrad (2005) claimed that important agents of medicalization are grassroots 
organizations and lobbying groups. CHADD is both of these. Because it came relatively 
late in the 1980s, it was not the primary mover in that decade but its establishment 
paved the way to further medicalization of ADHD in the 1990s. What CHADD and the 
two versions of the DSM released in the 1980s did represent was cohesiveness. The 
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DSMs illustrated a professional agreement that went beyond the individual studies 
performed in previous decades. The creation of CHADD illustrated that the culture had 
accepted the diagnosis and would help in its promotion. While Ciba was active in the 
1980s, its activities are overshadowed by this impressive display of acceptance. 
Medicalization no longer required individuals; ADHD had been swept up into the 
therapeutic state. Sales and growth of the DSM alone testify to this. ADD and ADHD 
were voted into existence in one decade, effectively coalescing all previous terms into 
one while lending credibility to the disorder. This, more than any other aspect of 
medicalization was responsible for the expansion of the diagnosis, not only in the 1980s 
but throughout the entire history of ADHD in any form. With acceptance in the 1980s, 
the 1990s was replete with scientific publications on the topic. The groundwork had 
been laid and all that was left was to build and expand.  
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Chapter 7 
A Social History of ADHD: 1990 Through 1999 
 
By the end of the 1980s, the diagnosis of ADHD had become established in 
American culture, exemplified by the establishment of CHADD. The disorder and the 
treatment had coevolved (Diller, 1998). The use of Ritalin for the treatment of ADHD 
expanded considerably (Hill & Castro, 2002) and was considered so conventional that, 
by 1990, 1,000,000 individuals were being medicated with stimulants (Baughman & 
Hovey, 2006). The study of ADHD had expanded in the 1980s; but in the 1990s it 
exploded. With the American Psychiatric Association’s support, the floodgates opened 
to a variety of investigations in the topic.  
Many studies made connections between ADHD and other disorders. ADHD was 
connected to a rare form of thyroid dysfunction called generalized resistance to thyroid 
hormone. It was reported that 70% of people with ADHD also suffered from this affliction 
(Hallowell & Ratey, 1994). ADHD was connected with Obsessive Compulsive Disorder, 
Bi-polar Disorder, Tourette’s Syndrome, serious language deficits, severe depression, 
substance abuse at a young age and being the recipients of sexual abuse (Brown, 
2005). In 1998, The Journal of Child and Adolescent Psychiatry reported that 97% of 
children diagnosed by a psychiatrist with the disorder were prescribed medication and 
49% of these children ended up on at least two different drugs (Baughman & Hovey, 
2006). Not only were these individuals were sick, they were very sick with multiple 
mental illnesses.  
 Many speculated on the function (or dysfunction) of the ADHD brain as well. 
Intelligence was reportedly unrelated to the disorder; and it was believed the diagnosis 
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spanned the entire intelligence spectrum. This conformed to some earlier theories. Even 
among those supporting the diagnosis they could not agree; another study claimed that 
ADHD brain used different and less efficient circuits to process information. Specifically, 
ADHD boy’s brains were unable to process information correctly; depending on the 
circumstance their brains either worked too slow or too fast. Calling back to previous 
studies, ADHD brains reportedly had abnormalities in processing dopamine. It was also 
discovered that those afflicted had excessive motor problems in addition to deficiency of 
attention. This indicated a serious neurological problem. Barkley proposed that ADHD 
was not simply a collection of these inabilities, but a problem in the executive 
functioning of the brain. This has since become one of the most prevalent views of the 
disorder (Brown, 2005). Not only were these individuals sick; they were very sick with 
multiple mental illnesses and had defective, inefficient brains. 
 Further studies reported on behaviors associated with the diagnosed. It was 
claimed that teens diagnosed with ADHD were more likely to have an STD, more likely 
to conceive a child, and less likely to use birth control. Drivers with ADHD reportedly 
had more collisions than those without. ADHD boys were also found to have a lower 
threshold for frustration and difficulty in regulation of subjective emotional expression. 
Those diagnosed were claimed to be less productive members of the society as well. 
Individuals with ADHD were reported to hold down a job for a shorter amount of time 
than those not diagnosed, and when medicated ADHD children had improved 
concentration on long boring computer tasks that they previously could or would not 
concentrate on. It was even found that those with ADHD could not even so much as tell 
a story as well as those not diagnosed (Brown, 2005). Not only were these individuals 
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sick, they were very sick with multiple mental illnesses, had defective, inefficient brains 
and could not perform simple tasks many take for granted. 
As in previous decades, much of the work done on ADHD concerned stimulant 
medications. In 1992, a team of experts chosen by the Department of Education 
examined the literature on stimulants. They claimed that “cognitive toxicity may occur at 
commonly prescribed clinical doses of stimulant medication” (Breggin, 2002, p. 32). This 
meant that stimulants can cause brain damage at the same dosage levels used in 
treating children with ADHD. The following year Swanson and colleagues released the 
results of a study revealing that there was no evidence that Ritalin resulted in any long-
term academic improvement among school aged children (Baughman & Hovey, 2006). 
A 1994 study of the effects of Ritalin on 69 children appeared to yield multiple side 
effects including depression and lethargy and adverse reactions similar to the zombie-
like effects described by others for decades (Breggin, 2002).  
Concurrently, the American Medical Association released the results of a study 
comparing Ritalin to cocaine. They concluded that methylphenidate (the generic name 
for Ritalin) caused nearly identical effects on the brain (Breggin, 2002). The same year 
the U.S. Drug Enforcement Administration cautioned that 20% of individuals on 
stimulant medications become depressed (Breggin, 2002). A separate study conducted 
at Broadlawn Medical Center (Des Moines) concluded that methylphenidate was the 
most “malignant addictive drug known to mankind” (DeGrandpre, 1999, p. 175). Such 
startling results are made even more shocking by a 1999 study that showed of 401 
pediatricians fewer than 40% even used the DSM for diagnosing children with ADHD 
(Baughman & Hovey, 2006). This meant that pediatricians were not only dispensing 
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these drugs, but they were not even relying on official guidelines in making the 
diagnosis that benefited from the treatment. No wonder 90% of the world’s supply of 
Ritalin was used in the United States (Breggin, 2001). 
Though some were apparently ignoring the document, in 1994 The American 
Psychiatric Association published a new edition of the Diagnostic and Statistical Manual 
of Mental Disorders. Understandably, the section pertaining to the disorder was not 
expanded as much as it had been in previous editions; ADHD was firmly established 
and required little embellishment. Nevertheless, the entry describing ADHD was 
augmented considerably with more detailed descriptions. There were, however, some 
notable changes beyond that. The new edition contained more specific explanations of 
hyperactivity, impulsivity, behavioral manifestations, and especially inattention. 
Where the diagnosed were referred to as “people” in the previous edition (DSM-
III-R, 1987, p. 50) they were referred to as “individuals” in the new edition (DSM-IV, 
1994, p. 78). The DSM was becoming increasingly adult oriented, giving examples such 
as individuals being distracted by “a car honking,” “missing appointments” and having 
trouble concentrating on paperwork (pp. 78-79). Most importantly, references to adult 
patients became more explicit. In the discussion of age in the previous editions, only 
childhood and adolescence were discussed. The DSM-IV (1994) added: 
In adulthood, restlessness may lead to difficulty in participating in sedentary 
activities and to avoiding pastimes or occupations that provide limited opportunity 
for spontaneous movement. (e. g., desk jobs) (p. 82) 
Of equal note, while many scientists and doctors claimed to have produced biological 
evidence for the disorder in the years since the previous edition, the manual concluded, 
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“there are no laboratory tests established” to detect and diagnose ADHD and “there are 
no specific physical features associated with Attention-Deficit Hyperactivity Disorder” (p. 
81). 
While the DSM held considerable weight in the diagnosis of ADHD, there were 
other books published in this decade that were regarded as expert. One of these was 
John Ratey and Edward Hallowell’s book, Driven to Distraction. This document has 
been described as being “the single most powerful force in the subsequent proliferation 
of the [ADHD] diagnosis” (Eberstadt, 1999, p. 161). Aimed at ADHD adults, it promoted 
the diagnosis of ADHD in children and adults as well as the routine use of stimulant 
medication. Not only did the authors advocate stimulant use, they advocated the use of 
multiple stimulants on one patient. Hallowell and Ratey (1994) provided a self-
assessment list for ADHD. Symptoms included: being left handed or ambidextrous, 
moodiness, impatience, smoking, drinking too much, changing the car radio frequently, 
gambling, strong intuition, hypersexuality, divorce, being a “maverick,” needy, adopted, 
highly allergenic, prone to ear infections as a child, claustrophobic, and love to travel (p. 
209-214).  
This list is as nebulous as the 1966 Sam Clements document that listed 99 
indicators of Minimal Brain Dysfunction, including: “spotty or patchy intellectual deficits,” 
“achievement low in some areas; high in others,” “distorted concept of body image,” 
“few, if any, apparent gross abnormalities,” “general awkwardness,” “slowness in 
finishing work,” “easy fatigability,” “thumb-sucking, nail-biting, head-banging, and teeth-
grinding,” “slow toilet train,” “sleep abnormally light or deep,” socially bold and 
aggressive,” “possibly antisocial behavior” and “physically immature, or physical 
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development normal or advanced for age” (p. 11-13). Since its publication, Driven to 
Distraction has become classic ADHD literature. While its historical facts are reliable, it 
loses usefulness as a diagnostic tool by adding confusion to an already vague 
diagnosis. It remains a highly referenced document, particularly in discussion of Adult 
ADHD. Illustrating the connectedness of those involved in the diagnosis, Hallowell and 
Ratey refer readers to the ADHD advocacy group Children and Adults with Attention 
Deficit/Hyperactivity Disorder (CHADD) for more information on the subject. At this time, 
however, CHADD had its hands full elsewhere. 
Because the popularity of ADHD increased, the use of stimulants also increased. 
Between 1990 and 1995 the production of Ritalin grew five-fold (Reiff & Tippins, 2004). 
Supporters of the drug continued to claim Ritalin helped ADHD patients as previous 
research suggested. However, in the middle of the decade a scandal surfaced that 
suggested a connection between CHADD and Ciba. The relationship between the two 
entities lead to a special report on PBS in 1995 called “A.D.D. — A Dubious Diagnosis?” 
According to the report, the relationship between Ciba and CHADD began in 
1988; and for the next seven years Ciba had given close to $1 million to CHADD. In that 
time the membership had grown from 800 to over 35,000. There was also a 
questionable public service advertisement produced by CHADD that had actually been 
paid for by Ciba (Merrow, 1995). While CHADD claimed to be independent, money 
talks; this is evidenced by CHADD’s lobby to get Ritalin removed from the list of 
Schedule II drugs in 1994 (Hill & Castro, 2002). This was done on the grounds that the 
stimulant was not addictive (Woodworth, 2000). Curiously, Ciba donated $400,000 to 
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CHADD during that time (DeGrandpre, 1999). That was 8 times the amount of money 
donated in 1991. Breggin (2000) explained that if the lobby had been successful it 
Would have relieved [Ciba] of having to go to the DEA each year in order to get 
approval for the gross amount of Ritalin that it manufactures. It would have 
relieved doctors of the necessity of writing prescriptions, rather than calling them 
in, for Ritalin. It would have been a boon to [Ciba] and organizations like CHADD 
that support the concept of ADHD and the use of stimulant drugs. (p. 71) 
That meant money in Ciba’s pocket, and CHADD’s as well. The DEA “conducted an 
extensive review of the use, abuse liability, actual abuse, diversion, and trafficking of 
methylphenidate” (Woodworth, 2000) and concluded that CHADD’s claim did not reflect 
reality; CHADD consequently withdrew the petition.  
The relationship between CHADD and Ciba seemed to have waned after Ciba 
merged with the Swiss company Sandoz in 1996, creating Novartis. Whether the 
disconnection between the two had to do with the merger or the controversy is 
uncertain; however, the monetary support went from $137,000 in 1996 to $65,000 in 
1997 and continued to decline. Nevertheless, the financial boost needed to expand the 
advocacy group and diagnosis had already been given by a number of pharmaceutical 
companies. Breggin (2001) reported: 
For the year ending June 30, 1997, Richwood Pharmaceutical, the maker of the 
amphetamine Adderall, gave $118,000. Abbott Laboratories (Cylert) gave 
$27,000, SmithKline Beecham (Dexedrine) gave $2,500, Glaxo Wellcome 
(Wellbutrin) gave $3,500, Wyeth Ayerst (Effexor) gave $9,150, Pfizer (Zoloft) 
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gave $5,000, and Alza (maker of a testosterone skin patch) gave $10,000. (p. 
234) 
Along with these companies, Ciba helped CHADD get off the ground. In an act of 
reciprocity, CHADD had popularized ADHD and other childhood disorders, increasing 
sales of Ritalin and other pharmaceuticals.  
Exposing CHADD’s connection with drug companies intensified discussion of the 
diagnosis. Eberstadt (1999) reported that since the middle of the 1990s:   
Interested parties from all over – the Drug Enforcement Administration (DEA), the 
Food and Drug Administration (FDA), the medical journals, the National Institutes 
of Health (NIH), and especially the extremely active advocacy group CHADD 
(Children and Adults with Attention Deficit Disorder) – further stoked the debate 
through countless reports, conferences, pamphlets, and exchange on the 
Internet. (p. 161) 
Along with the research and development of ADHD, events were unfolding on a 
political, social, and economic scale. A 1991 addendum to the Individuals with 
Disabilities Act of 1990 afforded special compensation to children who were 
unmanageable in the classroom and needed special educational requirements. This 
allowed children diagnosed with ADHD to receive special compensation in school even 
without a specific law regarding ADHD (Reiff & Tippins, 2004). And toward the end of 
the decade the National Institute for Health called a conference to examine the 
evidence of ADHD and make a decision on its validity. This was in response to the 
controversy surrounding the disorder and its treatment. After reviewing the scientific 
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data, the panel concluded that Attention-Deficit Hyperactivity Disorder was real. In a 
statement issued at the close of the conference, the panel said: 
The diagnosis of ADHD can be made reliably using well-tested diagnostic 
interview methods. However, as of yet, there is no independent valid test for 
ADHD. Although research has suggested a central nervous system basis for 
ADHD, further research is necessary to firmly establish ADHD as a brain 
disorder. (NIH, 1998, p. 17) 
Reflecting the wisdom steeped in the traditions of psychiatry, psychology, and 
pediatrics, much of what the panel stated was in agreement with what the DSM claimed 
about the disorder. The panel continued:  
Although little information exists concerning the long-term effects of 
psychostimulants, there is no conclusive evidence that careful therapeutic use is 
harmful. (p. 32) 
Though the committee claimed to be impartial, there have been serious allegations 
contesting that. The conference was planned by the staunch ADHD advocate Peter 
Jensen, and David Kupfer, the chairman of the objective consensus panel, had 
“received particularly extensive funding from NIMH for research based on the supposed 
validity of the ADHD diagnosis and stimulant treatment” (Breggin, 2001, p. 11). In 
addition, The National Institute of Mental Health, the organization running the 
conference under the authority of the National Institutes of Health had “failed to invite 
any critics of the medication to speak at the conference and planned no specific 
presentation on adverse drug effects” (p. 11).  
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 Peter Breggin appealed to the institutes to provide a more balanced conference. 
He alone was added to the list as a presenter at the conference, making a total of four 
out of thirty presenters raising concerns over the safety or efficacy of these medications 
(Breggin, 2001). On the side supporting the diagnosis and treatment were academics 
such as outspoken stimulant proponent Russell Barkley as well as Joseph Biederman, 
who clamed that 10% of school-aged children in America had ADHD (Diller, 1998). This 
is well above the DSM’s estimates. Because of the sex ratio among the diagnosed, this 
would mean one in six boys between 5 and 12 should be treated for the disorder (Diller, 
1998).  
Further evidence calls into question the reliability of the decision made at the 
conference. Among the scientific studies cited as evidence of a biological basis for 
ADHD was a famous 1990 study by Alan Zametkin. A doctor at the National Institutes of 
Health, Zametkin published the results of a then recent brain study he conducted in the 
New England Journal of Medicine.  Zametkin found that those with ADHD had a 
statistically significant lower rate of chemical activity in specific and global regions of the 
brain when performing a sustained task (Brown, 2005). Those with the disorder were 
said to metabolize glucose at an 8% lower rate than the non-ADHD controls. Using PET 
scans to create images of the brain, a test was designed to measure the attention spans 
of the diagnosed. Deficiencies in the frontal lobe of the brain were said to be consistent 
with previous scientific analyses of the disorder (Hallowell & Ratey, 1994). This study 
appeared to confirm the frontal lobe hypothesis and finally made credible the biological 
basis for ADHD. There were, however, questions raised about the validity of the study. 
DeGrandpre (1999) pointed out a number of flaws in Zametkin’s research: 
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First efforts to replicate the findings reported by Zametkin et al. have failed; 
numerous studies have followed up this report, with little to show in return. 
Second, the participants were adults rather than children, thus limiting the 
applicability of this study for children. Third, there remains no evidence that a 
mere 8.1 percent difference in metabolism would produce clinically significant 
difference in behavior, including hyperactivity; as students of statistical testing 
should know, statistical significance should not be interpreted to mean clinical 
significance. (p. 141) 
Furthermore, DeGrandpre also suggested that the difference in metabolism was 
the result of an uneven sex ratio, claiming “while 72 percent of participants in the 
hyperactive group were men, in the control group the number was 56 percent” (p. 142). 
The results of the study could also suggest that men have a lower glucose uptake in 
that particular part of the brain, and in fact “another group of researchers compared the 
metabolism between the men and women in the control group of the Zametkin study 
and found just such a statistical difference in metabolism” (DeGrandpre, 1999, p. 142). 
Although the study may have questionable flaws, it continues to be used as an 
argument for a biological basis for ADHD as a disorder. 
 Combined with other concerns, the inclusion of such scientifically flawed 
evidence at the conference nullifies any decision they made. It also raises serious 
questions about the quality of all the studies sanctioned at high levels of government 
where major decisions regarding the validity of the ADHD diagnosis and the efficacy of 
stimulant medications are made. That being the case, the next year the National 
Institutes of Mental Health encouraged physicians to use stimulants, claiming that they 
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produced far more improvement of ADHD symptoms than other forms of intervention 
(Brown, 2005). The government had officially decided that ADHD was a genuine 
disorder and stimulants were the most effective treatment. The authenticity was not only 
supported by the pediatric, psychiatric, and academic communities, but it enjoyed the 
full weight of the government as well.  
 The diagnosis expanded from an estimated 900,000 to an estimated 5 million 
towards the end of the decade and Ritalin production increased some 700 percent 
(Diller, 1998). Research on the subject grew exponentially, effectively furthering its 
medicalization. However, CHADD, Ciba and the United States Government did more to 
further the diagnosis than anything else in the 1990s. While the early years of ADHD 
study had been done independently, many of the experts were, by this time, part of 
larger organizations. They were board members of CHADD and involved in the National 
Institutes of Mental Health. There was interconnectivity between. As individuals, they 
could only do so much but as a cohesive unit they embodied the “power and authority of 
the medical profession” that Conrad (2005, p. 4) claimed as an agent of medicalization.  
 During this decade Ciba supported CHADD financially and the results were 
stellar. Ritalin lead the nation as the most commonly used stimulant in the treatment of 
ADHD. The 1990s produced a rapid expansion of the diagnosis. Though the consensus 
conference made great strides in affirming the acceptance of the diagnosis in the lay 
community, it did not end the debate. Fresh theories presented in the 2000s will call into 
question the validity of the diagnosis. ADHD will continue to expand and ADHD will 
further be accepted into the adult realm, opening up the possibility of adults with no prior 
diagnosis to be labeled.  
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Chapter 8 
A Social History of ADHD: 2000 Through 2009 
 
By the end of the 20th Century ADHD was firmly established. It permeated every 
level of American society from the United States Government down to the individual 
level. People from all walks of life were involved in its medicalization. Much of the 
argument that had been going was quieted by the National Institutes of Health. The 
legwork had been done; stimulants, by the 21st Century, had become ubiquitous. Where 
Ritalin dominated the market in the 20th Century, by the 21st Century Adderall surpassed 
it in sales. In 1997 Adderall sales brought in $19 million. The figure rose to $200 million 
by 2000 and by 2002 Adderall sales represented 40% of Shire's income, bringing in 
$400 million (Baughman & Hovey, 2006).  
A 2006 estimate claimed 7 million people had misused stimulant medication 
designed to treat ADHD and 75,000 showed signs of addiction. One Boston Globe 
article reported that teachers coerced parents into treating their children (Breggin, 
2001). Even a respected board member of CHADD discussed the possibility of legally 
enforcing treatment for ADHD in a USA Today article (Baughman & Hovey, 2006). 
On college campuses and in high schools, students have been routinely using 
Ritalin and Adderall as brain steroids. A recent news article reported “Adderall and 
Ritalin have become the drugs of choice for students looking for a brain gain”. One 
student claimed that 80% of the students he knew used ADHD stimulant medication to 
get an edge in school (O’Mara, 2009, p. 2). The problem has become so widespread 
that a simple search of “ADHD Medication” on the Google news search engine will 
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render multiple hits on news articles discussing stimulant abuse in the college 
population. Television news reports and specials on the problem are common. 
Like the 1990s, much of the study in the 2000s revolved around the comorbidity 
of ADHD with other disorders. These studies included links to Dyslexia, Dysthymia, 
Depression, Anxiety Disorder, Obsessive Compulsive Disorder, mathematics disorders, 
reading disorders, and written expressions disorders. Presumably a full 88% of those 
diagnosed with ADHD also suffered from one other disorder in their lifetime (Brown, 
2005). So much research was done on the diagnosis that the American Academy of 
Pediatrics estimated that about 1000 articles are written about it annually (Reiff & 
Tippins, 2004). Understandably, the vast majority of these are in support.  
Arguably one of the most important papers contradicting the assumptions about 
ADHD was an extensive literature review of brain imaging scans used to indicate a 
biological basis for the disorder. After reviewing more than thirty neuroimaging studies, 
Leo and Cohen (2003) found serious scientific flaws in all of them. The most common 
was that many test subjects had been on stimulant medication for extended periods of 
time prior to the study. Since stimulant medication is known to cause neurological 
damage, any data gathered from these studies is dubious at best. Other deficiencies 
include the use of non-comparable control groups and the possibility of rival explanatory 
factors. Leo and Cohen (2003) concluded: 
After twenty-five years and thirty-five studies, there is not a single straightforward 
experiment comparing typical unmedicated children with an ADHD diagnosis to 
typical controls. We are perplexed. (p. 51)  
 69 
As recent as March 27, 2009, the Washington Post published a news article announcing 
the results of a “large federal study” into the effectiveness of stimulant medication for 
the treatment of ADHD (Vedantam, 2009, p. 1). Not only did the study indicate that such 
medications were ineffective, it also demonstrated that stimulant medication might be 
harmful (Vedantam, 2009). One of the principal scientists of the investigation concluded 
that stimulant medication was effective in the short term but lost effectiveness in the 
long term: 
“People are embarrassed to say they were wrong and we led the whole field 
astray," said Pelham, of the State University of New York at Buffalo. Pelham said 
the drugs, including Adderall and Concerta, are among the medications most 
frequently prescribed for American children, adding: "If 5 percent of families in 
the country are giving a medication to their children, and they don't realize it does 
not have long-term benefits but might have long-term risks, why should they not 
be told?” (Vedantam, 2009, p. 5) 
The response from the medical, psychiatric and public advocacy communities 
like CHADD was to deny the findings and claim that the study was biased against the 
use of medication (Vedantam, 2009). Occasionally, supporters of the medication re-
confirm the effectiveness of the treatment through scientific studies, as was done shortly 
after this article was published. Continuing a 30 year trend, the American Psychiatric 
Association published a new manual for a new decade. 
At the beginning of the decade the newest version of The American Psychiatric 
Association’s Diagnostic and Statistical Manual of Mental Disorders was released. The 
previous decade ended with a government sanctioned diagnosis of ADHD in children. 
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This new version of the DSM, in addition to a general expansion of the diagnosis, finally 
confirmed the presence of ADHD in adults. The DSM-IV (1994) referred to ADHD “in 
adulthood” saying “restlessness may lead to difficulty in participating in sedentary 
activities and to avoiding pastimes or occupations that provide limited opportunity for 
spontaneous movement (e. g., desk jobs) (p. 82). The DSM-IV-TR (2000) elaborated: 
Caution should be exercised in making the diagnosis of Attention-
deficit/Hyperactivity Disorder in adults solely on the basis of the adult’s recall of 
being inattentive or hyperactive as a child, because the validity of such 
retrospective data is often problematic. Although supporting information may not 
always be available, corroborating information from other informants (including 
prior school records) is helpful for improving the accuracy of the diagnosis. (p. 
89) 
Because of diagnostic changes, the DSM-IV-TR (2000) also expanded the percentage 
of school-age children estimated to have ADHD from 3%-5% to 3%-7%. Though the 
manual made no qualms about labeling more children, it concluded that there are no 
medical tests to detect the disorder’s presence. 
This expansion has lead to people being diagnosed well into adulthood. For 
instance, an April 2009 news article reported that a 55 year old man was diagnosed for 
the first time in his life, furthering an estimate that 700,000 Canadian adults have the 
disorder that has heretofore gone largely undetected (Man Turns Life Around, 2009). 
Currently organizations like Attention Deficit Disorder Association and Children and 
Adults with Attention-deficit Hyperactivity Disorder advocate for the diagnosis of ADHD 
in adults. Because so many adults are now struggling to live with their ADHD, the 
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popularity of the ADHD Coach has skyrocketed. This is an artifact of the Adult ADHD 
movement in the 1990s, spearheaded by Hallowell and Ratey’s Driven to Distraction. 
According to Little (2001), ADHD coaching is 
An ongoing relationship which focuses on the client taking action toward the 
realization of their vision, goals or desires. AD/HD coaching uses a process of 
inquiry to discover ways in which a client can maximize strengths and talents, 
function optimally with a disability, and be responsible and accountable for 
actions or lack of action. AD/HD coaching provides clients with structure, support, 
skills and strategies. (p. 1) 
A coach is not difficult to find. The internet is flooded with them. Clients can retain one 
over the phone and many such coaches have internet sites to promote their services. 
There is no official medical certification and literally anyone can do it after a few classes 
at one of the several coaching institutions across the United States and Canada. The 
educational background for these individuals varies and does not have to be in the 
mental health field. For example, one coach holds degrees in education, art, and history 
(Gordon, 2009). Another holds a degree in Political Science (Quilly, 2003). Still others 
feel no need to report any education leaving one to wonder if they have any legitimate 
credentials.  
ADHD has become so conventional that it has infiltrated the adult population. 
There are jobs specifically created to deal with this adult ADHD epidemic. It has been 
accepted to the point people are being diagnosed with a traditionally childhood disorder 
well into their 50s. Naturally, along with this, pharmaceutical companies have become 
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very wealthy and authoritative. These corporations not only have enormous financial 
resources, they have a loud voice in politics and culture.  
The pharmaceutical industry is enormously powerful, powerful enough to strongly 
influence everything from the classification of new psychiatric disorders, medical 
research, medical training, information given to educators, the position of mental 
health advocacy groups, and the federal government itself. (Baughman & Hovey, 
2006, p. 173) 
One news article from The Guardian supports this, stating: 
In the past two decades the US has moved steadily toward a market-based 
healthcare system. In this system, the pharmaceutical industry has achieved 
unprecedented financial power. Since the early 1990s, the pharmaceutical 
industry has been the most profitable industry in America, with margins 
exceeding 18%. With profit has come power. (Elliott, 2003, p. 3)  
The companies have infiltrated a vast area of culture and even influenced American 
elections. 
In the 1999-2000 election cycle, the drug industry spent more money on political 
lobbying than any other industry, more than the oil and gas industry, more than 
tobacco, more than the insurance or automobile industry. (Elliott, 2003, p. 4) 
While the pharmaceutical companies, advocacy groups, and political action 
groups continue to fight for a firm establishment of the disorder, expanding it along the 
way, recent studies unassociated with the American pharmaceutical companies and 
medical community are rendering startling results. One of the most important scientific 
breakthroughs in ADHD studies was the link discovered with the DRD4 gene. The 
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behavioral patterns for ADHD are strongly associated with certain mutations of this 
gene. And while having a certain mutation in this gene does not confirm an ADHD 
diagnosis, it does suggest a genetic predisposition for the development of the behaviors 
(Winstead, 2000).  
While some would use the DRD4 gene as proof that ADHD is a genetically based 
disorder, further research indicates differently. Three anthropologists and a biologist 
conducted a study of a Kenyan tribe that was partially nomadic and partially settled in a 
westernized environment. Eisenberg and his colleagues (2008) measured the body 
mass index of those with the gene both in the nomadic society and in the settled 
society. They concluded: 
Frequencies of the DRD4/7R and DRD2/A1 alleles were 19.4% and 28.2%, 
respectively and did not differ between the nomadic and settled populations. BMI 
was higher in those with one or two DRD4/7R alleles in the nomadic population, 
but lower among the settled. (p. 2) 
They found that among the part of the tribe living within a non-western, tribal culture, 
those with the ADHD associated gene had greater overall health than the rest of the 
tribe, including a higher body mass index. The researchers hypothesized: 
Increased impulsivity, ADHD-like traits, novelty-seeking like traits, aggression, 
violence and/or activity levels may help nomads obtain food resources, or exhibit 
a degree of behavioural unpredictability that is protective against interpersonal 
violence or robberies. Increased activity levels, if not resulting in increased food 
access, likely would decrease nutritional stores. The 7R allele might also 
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promote better infant survival depending upon the social and ecological context. 
(Eisenberg, et al., 2008, p. 6) 
While further study is required in this area, this study suggests that ADHD may be a 
culturally based “disorder” and beneficial under certain social conditions.  
While the diagnosis of ADHD was expanded at the inception of the decade, 
throughout the course of the 2000s it has been called into question despite the National 
Institutes of Health Conference on its validity. Thomas Szasz (2007) asserted that the 
reasons we are told that certain behaviors are illnesses are that deep down as human 
beings we know that it is not true. The medicalization of activity and distractibility has 
produced many outcomes. Children, and now adults, are controlled a little more tightly. 
Money is being made with every prescription; and a black market flourishes with college 
students illegally consuming stimulant medication.  
The diagnosis is part of culture yet dissenters continue to point out flaws, 
combating the diagnosis with studies of their own. Chapter 9 will return to the theoretical 
foundations of the therapeutic state and medicalization. It will discuss the theories put 
forth by Nicholas Kittrie and Peter Conrad and explain the significance of Max Weber’s 
theories on the rationalization of society. It will also address arguments over the 
diagnosis and offer suggestions for further areas of research.  
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Chapter 9 
Theoretical Review and Conclusion 
 
Since it was first created, ADHD has been controversial; it is a behavioral 
disorder that cannot be measured like other illnesses. It is diagnosed by a professional 
who recognizes the symptoms and writes a prescription (Gaviria, 2008). Diagnosis is a 
guessing game; treatment is given before one is confirmed and the treatment confirms a 
diagnosis if it calms the patient. The tautological reasoning for its existence is apparent 
in this procedure. The current admission among the psychiatric and mental health 
communities is that there is no empirical test for ADHD. Those in the mental health field 
admit it cannot be biologically tested for, but they as trained individuals simply recognize 
the symptoms and that is good enough. This leaves the diagnosis wide open for 
interpretation and expansion. With undefined parameters and tautological reasoning it is 
conceivable that, with persistence, any child or adult could be diagnosed with ADHD.  
It has become evident that brain dysfunctions among those with ADHD are not 
medicated; activity is. Activity that is hard to control is “treated”. If “sufferers” were 
enthusiastically hyperactive in submitting to authority, sitting quietly, quickly finishing 
given work, performing chores dutifully, and conforming to rules without question, there 
would be no need for medication (Baughman & Hovey, 2006). ADHD is a product of the 
medicalization process.  This occurs when “previously non-medical problems are 
defined and treated as medical problems, usually in terms of illnesses or disorders” 
(Conrad & Leiter, 2004, p. 158). This is a dry definition; McLeod and colleagues (2004) 
elaborate: 
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Classic writings on medicalization critiqued the medical profession’s promotion of 
medical interpretations of social problems, its use of medications whose long-
term efficacy has not been documented, and its efforts to expand its boundaries 
and power base at the expense of public safety and well-being. (p. 54) 
This is most certainly what has happened with ADHD. Reality, in this view, is socially 
constructed (Conrad & Schneider, 1992) and the “greatest social control power comes 
from having the authority to define certain behaviors, persons and things” (Conrad, 
1992, p. 216). The therapeutic state has increased its power base for decades and 
carries with it the ability to define behaviors and individuals. It has, on numerous 
occasions, used harmful medications and techniques to control those deemed sick.  
Though the concept of the therapeutic state originated in the 1970s, the 
groundwork for its understanding was laid nearly a century before. Thomas Armstrong, 
psychologist in the field of multiple intelligences, posited that those with ADHD are 
naturally disinclined to fit in the capitalistic society shaped by what Weber (1946) called 
the Protestant Ethic. Those who thrive in this society value systematic and tedious work 
for self-betterment. Armstrong (1997) asserted that “such a society might well be 
expected to define deviance in terms of distractability, impulsiveness, and lack of 
motivation” and that diagnosing children with ADHD “may represent a means through 
which our society attempts to preserve its underlying value system” (p. 27). Many of 
Weber’s ideas can be applied toward the understanding of the ADHD label. 
The development of a therapeutic state is just one aspect of what Weber (1946) 
described as an increased rationalization of society. He asserted that society was 
becoming more mechanized and finding more ways to routinize life and streamline 
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efficiency. “Precision, speed, ambiguity, knowledge of files, continuity, discretion, unity, 
strict subordination, reduction of friction, and of material and personal costs” are “raised 
to the optimum point” in this kind of society (p. 214). A rationalized society is a highly 
structured and ordered world where standing in line and red tape are the norm. The 
justice system has been charged with keeping order in this kind of society but the 
medical and psychiatric communities have recently taken a more active role in bringing 
into line those who deviate from the norm but are not so deviant as to be labeled 
criminal (Kittrie, 1977). For this task, deviant behavior needs to be labeled. To be 
legitimate these behaviors have to become medicalized. 
The claim, “one way or another, the medical profession and the expansion of 
medical jurisdiction was a prime mover for medicalization” (Conrad, 2005, p. 4) fits 
when examining the medicalization of ADHD. This is a diagnosis pioneered by the 
medical profession. Parents used to punish their children with corrective behavior and, 
at times, employ the use of hard drugs. At the beginning of the 20th Century, the medical 
community spearheaded the “sick” label for these behaviors. Early mention of ADHD-
like traits appeared in medical journals and only dealt with childhood hyperactivity. They 
consisted mostly of speculation on the cause of the disorder or stimulants’ unusual 
ability to counteract socially disruptive behaviors. This has expanded considerably since 
and many of the same arguments of that time are heard today. 
Medicalization “sometimes occurred through the activities of social movements 
and interest groups” (Conrad, 2005, p. 4). In such cases, these groups “champion” the 
problem and advocate for its cultural acceptance. In the late 1980s, Children and Adults 
with Attention-deficit Hyperactivity Disorder (CHADD) popularized the diagnosis of 
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ADHD. Although they did not invent the diagnosis, with the financial backing of drug 
companies they were a key component in the establishment of the disorder. They also 
popularized the idea that adults could suffer from ADHD before the DSM expanded the 
diagnosis to include them. In some sense they helped to create the adult ADHD 
diagnosis. 
Serious medical discussion of behaviors associated with ADHD happened shortly 
after the United States Government outlawed the free commerce in hard drugs that 
were given to keep children calm and docile. This facilitated the direct supervision by 
the medical community of any drugs given to children for the “treatment” of 
hyperactivity. There was nowhere for these behaviors to go except the medical 
community, and they were happily assimilated. Conrad (2007) explained that, 
professions competing “for authority in defining and treating problems” spurred on the 
medicalization process (p. 9). The absorption of hyperactivity into the medical 
community opened the door for psychologists, psychiatrists, and pediatricians to make a 
name for themselves by becoming experts in hyperactivity. This factor was important in 
the beginning of the diagnosis.  
In the 20th Century, there was a change in the way medicalization evolved. 
Medicalization became profitable and health and medicine became much more 
consumer driven (Conrad, 2005). Pharmaceutical companies began to market drugs as 
consumables and individuals became consumers who, at times, asked for drugs by 
name. Pharmaceuticals have become one of the most profitable industries in America 
and the medical community carries considerable political weight, actively lobbying in 
Washington (Elliott, 2003). In 2007 Thomas Szasz said, “People do not have to be told 
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that malaria and melanoma are diseases. They know they are. But people have to be 
told, and are told over and over again, that alcoholism and depression are diseases. 
Why?” (p. xxiii). Because it is profitable; it has economic and social benefits. The 
medicalization of ADHD is among those stories “so emblematic of a particular time and 
place that they demand to be designated cultural landmarks” (Eberstadt, 1999, p. 159). 
The growth of the medical community’s active intervention in the lives of so many 
children and adults is a clear marker of the therapeutic state and is a natural extension 
of the bureaucracy.  
 Kittrie (1977) claimed, “The growth of new controls in the area of mental health, 
alcoholism, drug addiction, and juvenile delinquency has become a national 
preoccupation, if not a passion” (p. 6). This is even truer today. His primary concern was 
with rights of institutionalized patients. This is no longer an issue but the therapeutic 
state has adapted. Modern society has evolved so that millions of children and adults 
have become out-patient institutionalized individuals who have undergone what can 
only be described as a chemical lobotomy. The nature of the bureaucracy demands a 
quick, efficient means to end social deviance; with the removal of institutionalization, 
medication is the logical choice.  
 Because of the compulsory nature of “treatment” for deviance, medicating 
children with psychoactive drugs for ADHD is part of what Szasz (2007) called 
“psychiatric oppression” (xxvi). Children have been coerced by parents into believing 
they have a sickness; these parents have been convinced by representatives of the 
therapeutic state that this is true. Those administering the medication have enlisted the 
help of the child in “treating” his or her own “sickness” (Lasch, 1991). This socializes 
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more individuals into the therapeutic state and leads to acceptance of the label into 
adulthood. This cycle has reinforced the diagnosis to the point that it is possible to “see 
it everywhere” (Hallowell & Ratey, 1994, p. 3). Society has become so dystopian that 
individuality is corrected by drugs. This is compulsory at early ages; however, the goal 
is to enlist the help of the victim. Cooperation ensures the easy function of the 
bureaucracy. 
The fault does not lie with individuals. Parents have been socialized to trust 
doctors due to the prestige of the profession. Medical knowledge has increased, thus 
increasing the difficulty to earn the title “doctor”. Medical professionals speak a 
language that is generally inaccessible to the lay public. This leads to a gulf of 
knowledge where patients must trust doctors. It would be easy to blame individuals in 
the therapeutic state. However those in the psychiatric and medical communities cannot 
carry the entire blame; they are simply gears and cogs in the bureaucracy. They have 
been trained in the worldview where certain deviances are sick.  
The relentless tendency to define problems as the result of individual failure or 
deficiency is, in part, a reflection of the training that most practitioners in the 
helping professions receive. Most have been trained in identifying and 
addressing individual pathologies, not in understanding the problems of the 
family as an institution, much less those of the larger society. (Currie, 2004, p. 
148) 
Medical training does not include a wide understanding of social contexts of varying 
complexity. This leads to a “worldview so deeply ideological as to be disconnected from 
elementary reality” (p. 147). Mental health professionals are not intentionally involved in 
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social control but “if your only tool is a hammer, every problem becomes a nail” (p. 148). 
This problem is exacerbated because the modern therapeutic state sees everyone as a 
nail. Medicalization of deviant behaviors has become so intrusive in the United States 
that 
American psychiatrists, in their eagerness to include all varieties and vagaries of 
human feelings and behavior in their professional domain, are running the risk of 
trying to medicalize not only psychiatry but the human condition itself. (Chodoff, 
2002, p. 3) 
New research lends considerable credibility to this claim.  
On a March 31, 2009 radio program, Dr. Richard Silberstein, director of the Brain 
Sciences Institute at Swilburne University in Melbourne, Australia, discussed recent 
findings on ADHD brain patterns. According to his research, neurological patterns of 
ADHD individuals are “quite different” than those of non-ADHD individuals. He reported 
that disordered subjects had an “increased communication between the back of the 
brain and the front of the brain” and concluded: 
There is a lot of evidence that a very high proportion of entrepreneurs, 
innovators, and inventors would have been diagnosed with ADD or ADHD had 
those labels been around at the time. (Hartman, 2009) 
This suggests that the medical community has “pathologized a way of thinking”. He 
compared the brains of ADHD people and those traditionally viewed as creative and 
came to the startling conclusion that: 
The more creative they were, the stronger was that very pattern we saw in that 
ADHD group, which was the back of the brain; the parietal occipital region talking 
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to the frontal region. And I must admit that was really one of the most exciting 
moments I've had in a long time because seeing that pattern so clearly suddenly 
made a lot of sense. (Hartman, 2009)  
Describing the results as “staggering,” he expressed the need to “rethink what ADHD is” 
and, excluding extreme pathological cases, that maybe a “normal part of our thinking 
style is being pathologized”. This study raises serious questions about the social control 
aspect of this diagnosis and calls into question the medical community’s claim to label 
these behaviors as sick.  
Research like Silberstein’s and Eisenberg’s DRD4 gene study on Kenyan tribes 
places the diagnosis in a cultural arena. In fact, many of the tasks which ADHD 
individuals were reportedly deficient in are culturally constructed. For example: ADHD 
people are reportedly poor drivers. The vehicle is a modern invention, not a human 
necessity. ADHD people are reportedly bad at sitting at a computer performing tasks for 
extended periods of time. The invention of the computer is even more recent; and 
already American society is completely dependent on it. ADHD people are reportedly 
bad at holding employment. Contemporary employment reflects modern conceptions of 
time and capitalistic ideals. This type of work has no power beyond what it is handed by 
society. In tribal and undeveloped societies, work was directly related to survival. There 
were no jobs as we know them today. People generally lived hand to mouth. Research 
indicates that not only would ADHD individuals be able to live free from these 
constrictions, they would be healthier than everyone else doing it (Eisenberg, 2008). 
Evidence suggests that those with ADHD can not nor will not adapt to what is most 
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certainly a social landscape that has become unnatural. Humanity has departed from 
nature and become bureaucratic.  
 Three questions were raised in the introduction. The first of these is: how has 
society, and particularly, the medical community changed to allow the medicalization of 
hyperactivity and social control of active children? Society has been moving in the 
direction of increased efficiency since the establishment of the bureaucracy. Weber 
wrote about this nearly a century before Kittrie noted the development of what he called 
the therapeutic state. This therapeutic state is a mechanism for controlling the 
population under the bureaucratic society Weber described. This society has enlisted 
the help of the medical community in controlling deviant individuals and populations who 
have not violated cultural norms to the point their behavior is deemed criminal but 
remains disruptive.  
 The medical community has assimilated behaviors that once were not deemed 
medical. As the sale of drugs became more profitable, the medical community became 
more consumer-driven. Pharmaceutical companies market to medical professionals on 
a regular basis, and often market to patients through direct or indirect advertisement. 
With the advent of self-help books like Driven to Distraction, people with no medical 
knowledge often diagnose themselves then seek a professional to confirm it. This is not 
altogether discouraged by the authors, who often are mental health professionals 
themselves, or by the drug companies who manufacture the treatment. Both of these 
groups profit. Teachers and school officials are now playing an increasingly significant 
role in diagnosing children with ADHD. It is not uncommon for schools to receive 
information packets or hold meetings where ADHD is discussed. This effectively leaves 
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untrained non-medical individuals to recognize symptoms and plant the seeds of a label 
in children. 
 The second question posed in the introduction was: how has the continuing 
diagnosis of hyperactivity in children expanded to include attention deficit hyperactivity 
disorder in both children and adults? This can be attributed to a number of factors. 
Previous to the 1980s there was no serious widespread discussion of ADHD adults. 
This expansion seems to be patient driven. The grassroots organization CHADD has 
been very active in its expansion. Children diagnosed with this disorder grew up and 
realized they did not change. Charismatic individuals like Hallowell and Ratey also 
promoted the idea. There was also no small help from drug companies. They provided 
funds to organizations like CHADD to promote the ADHD diagnosis. Adult ADHD 
effectively widens their consumer base. Further, the DSM increasingly broadened the 
diagnosis; first by changing nouns. Over the years, however, they gave more examples 
of adult oriented activities in relation to ADHD. Finally, the document explicitly expanded 
the disorder, including the heretofore unaffected portion of the population. 
 The third question posed was, what forces are behind the continuing diagnosis 
and why? The expansion and maintenance of the ADHD diagnosis could not have been 
possible had American society not been in a constant move towards streamlined 
efficiency for centuries. The inclusion of adults in the ADHD category was good for 
society and continues to be so. The treatment of such individuals with stimulants not 
only provides a quick and efficient answer to a societal problem, but it increases 
productivity and solidarity. Schools and offices profit by having more obedient students 
and workers. The drug and medical industry profit in the strictest sense as well; they 
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make millions of dollars a year on the diagnosis. ADHD has become an acceptable 
disorder to have. The term is fast losing its stigma so it is favorable above other 
diagnoses. It has been popularized to the point that some people who have never been 
diagnosed claim to have it. Lay people say things like “I think I have ADHD”. It has 
become a cultural landmark and firmly established itself in American slang. It has 
become the diagnosis de jure for those who have deviant behavioral problems. It is one 
of the top behavioral disorders in children; further, it is believed to exist when individuals 
react positively to stimulant medication, which is often easy to accomplish. Put simply, it 
is convenient.  
There has been no definitive proof in over 100 years of study that behaviors 
associated with ADHD are actually based on defective brains. No child or adult can be 
diagnosed based on an impartial scientific test. An average of 1,000 articles are written 
on the subject every year, yet the DSM (2000) still claims that there are no biological 
tests to prove it exists. Even one of its most charismatic spokespersons, Russell 
Barkley (2000), acknowledges the fact that it could be a natural phenomenon, yet 
claims treatment is needed nonetheless. The treatment, however, looks more like a 
treatment for society, and the blight is 5-10% of society who think differently than 
everyone else.  
Current society benefits from ADHD staying the mental disorder that it is. 
Untreated ADHD individuals are disruptive to modern bureaucracy. They do not stay in 
line. The do not sit in their seats. They do not strictly submit to authority. They say what 
they are thinking and they are free from social norms. ADHD individuals are creative 
and often think outside the box, and not always in ways that are economical or 
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profitable. Untreated, each one of these individuals is a wild card. Treated they fall in 
line with the norms and values of the larger society. The fact that any number of 
negative side effects to the individual may present is a minor concern when compared 
to keeping society streamlined. Potential dangers to individual persons simply do not 
account for much on the grand scale. 
Further research into this area is needed. Thousands of medical and psychiatric 
studies are released every decade with mixed success and credibility. However, 
comparatively little research is being done from a sociological, anthropological, or 
historical perspective. Credible work has been done by Breggin, DeGrandpre, Diller and 
others; however it is not up-to-date and much has been about stimulant dangers. There 
is a recorded history of drug use on children for the purposes of social control. A more 
in-depth look at the history of this prior to and after the turn of the 20th century would be 
useful in putting this argument into a larger context. An inspection of the rates of ADHD 
diagnosis per-capita in high population areas may shed light on a connection between 
the 20th Century population explosion and the medicalization of deviance for social 
control. And a comparison of the medicalization of homosexuality and ADHD would 
explore the political nature of unproven brain disorders and explain how ADHD can 
become demedicalized. There is plenty of room for growth in ADHD social research. 
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